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Abstract
Myelin is a multi-layered membrane which enwraps the axons in peripheral (PNS) and
central nervous system (CNS). The formation and assembly of this structure is a multi-
step process that is regulated by a variety of extracellular factors. In the CNS, myelin
is produced by oligodendrocytes. During development, the progenitors of these cells dif-
ferentiate into mature oligodendrocytes that start to enwrap axons by myelin membrane
sheaths after receiving the appropriate signal(s) from the microenvironment. However, the
responsible signals to initiate this process are unknown. Here, we showed that oligoden-
drocytes release small microvesicles, exosomes, into the extracellular space that prevent
the terminal differentiation of oligodendrocytes and subsequently myelin formation. These
inhibitory effects were revealed to be mediated by activity of the RhoA-ROCK signalling
cascade. Importantly, the exosome release by oligodendrocytes was significantly reduced
when cells were incubated with the conditioned medium from neurons. Our results sug-
gest that exosomes produced by oligodendrocytes maintain the cells in pre-myelinating
stage, whereas in the presence of neuronal signals, exosomes secretion by oligodendrocytes
is reduced and the autoinhibitory signals are relieved. Thus neurons may regulate the
formation and release of oligodendroglial-derived exosomes in order to coordinate myelin
membrane biogenesis and assembly.
In the second part of the thesis, the question of how myelin compaction is mediated was
addressed. Whereas MBP is known to organize the interaction between myelin membranes
from cytoplasmic side, the molecular mechanisms underlying the interaction between the
outer leaflets still remain unclear. In general, the interaction between two opposite mem-
branes requires the expression of adhesion molecules and the removal of repulsive com-
ponents. Therefore, we investigated the role of proteolipid protein (PLP), as a putative
adhesive molecule, and the glycocalyx, as a repulsive structure, during myelin compaction
in the CNS. We analyzed the adhesion of purified myelin particles with the primary oligo-
xix
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dendrocytes in order to mimic the interaction between myelin layers. Using this system we
showed that PLP increases the adhesiveness of myelin membrane. We also found that PLP
enhances physical stability of myelin using single particle force spectrometry. In addition,
we observed a significant reduction in the glycocalyx during oligodendrocyte maturation
which correlated with an increase in their surface affinity towards myelin particles. Fur-
ther analysis indicated that the negative charge of sugar moieties, mainly sialic acid, is
responsible for the reduction in myelin adhesiveness. Therefore, we propose that the ad-
hesive properties of PLP along with the reduction of the glycocalyx, orchestrate myelin
membrane adhesion and compaction in the CNS.
Chapter 1
Introduction
1.1 Central nervous system myelin
Myelin consists of a multi-layered stack of membranes which spirally enwraps axonal seg-
ments in the peripheral (PNS) and central (CNS) nervous system. Schwann cells and
oligodendrocytes (OLs) are responsible for myelination in PNS and CNS, respectively. Al-
though myelin has an identical function, the cell biology of its biogenesis by myelinating
glia is different in the PNS and CNS (Richardson et al., 2006; Chong and Chan, 2010).
Myelin is important as an axonal insulator, which is essential for generating rapid saltatory
impulse propagation of neuronal signal. In addition, this structure supports axonal sur-
vival and long term integrity by providing trophic factors (Nave and Trapp, 2008; Emery,
2010a). The importance of myelin is evident in pathological conditions such as multiple
sclerosis (MS) in which this structure undergoes severe distortion (Franklin and Kotter,
2008).
1.1.1 CNS myelin structure
In the CNS, myelin biogenesis starts by the branching of oligodendrocytes into multiple
cellular processes. Unlike Schwann cells which generate one myelin fragment, each oligo-
dendrocyte can produce up to 40 myelin segments. Moreover, every axon is myelinated
by several fragments (Baumann and Pham-Dinh, 2001). Electron micrographs of cross
sections from the optic nerve reveal two main domains in myelin: the tightly opposed
outer leaflets of the cell membrane form a less dark intraperiod line (IPL), and the closely
condensed cytoplasmic membranes create the dark major dense line (MDL) (Quarles et al.,
2006; Aggarwal et al., 2011a).
1
2 1 | Introduction
Figure 1.1: The structure of CNS myelin. In a myelinated axon four distinct regions are present;
internode (INT), juxtaparanode (JPN), paranode (PN) and nodes of Ranvier (N). The figure is
adapted and modified from Jackman et al. (2009). Reprint by permission from The American
Physiological Society Ltd: physiology, copyright (2009).
In myelinated axons, however, four distinct domains appear: internode, juxtaparanode,
paranodal loop, and nodes of Ranvier (Figure 1.1) (Jackman et al., 2009). The internode
is a compacted area of myelin where different membrane layers closely interact with each
other. This domain contains several characteristic proteins such as the proteolipid pro-
tein (PLP), myelin basic protein (MBP), myelin-associated oligodendrocytic basic protein
(MOBP) and myelin and lymphocyte protein (MAL) (Maier et al., 2008). The most inner
and outer myelin layers, however, are not compacted. These tongues encapsulate consid-
erable amounts of cytoplasm compared to the compacted layers. The myelin internods
are separated by non-myelinated nodal region where sodium channels are highly-dense
clustered (Quarles et al., 2006; Baumann and Pham-Dinh, 2001). In the paranodal re-
gion the interaction between myelin and axonal surface is organized. Therefore, this
domain contains specific adhesion molecules like myelin associated glycoprotein (MAG),
contactin, neurofascin 155 (NF-155), neurofascin 186 (NF 186), contactin-associated pro-
tein (Caspr), and neural cell adhesion molecule (NCAM)-120 to establish the axon-glia
interaction (Sherman and Brophy, 2005). The paranode is separated from the internode
by the juxtaparanode domain in which potassium channels are organized (Jackman et al.,
2009). Paranodes and juxtaparanodes are regions with a non-compacted myelin mem-
brane, which are separated from the compacted area by proteins such as oligodendrocyte-
specific protein (OSP)/claudin 11 (Kra¨mer et al., 2001; Maier et al., 2008).
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1.1.2 Myelin composition
Compared to other biological membranes, myelin unusually contains high amounts of
lipids. The CNS myelin consists of 70-85% lipids and only 15-30% proteins in its dehy-
drated form (Quarles et al., 2006).
1.1.2.1 Myelin proteins
The major proteins in the CNS myelin are PLP, MBP, CNPase (2’,3’-cyclic nucleotide 3’-
phosphodiesterase) and relatively low proportion of various glycoproteins.
PLP, also known as Folch-Lees protein, is a 30 kDa transmembrane protein with a highly
conserved sequence (Quarles et al., 2006). It contains four integral helix-spans into myelin
membrane, interconnected by three hydrophilic loops and both N- and C-terminal do-
mains of the protein are oriented towards the cytoplasm. The PLP gene is located on the
X-chromosome (Williams and Deber, 1993; Mo¨bius et al., 2008). The less abundant splice
isofrom of PLP, lacking a portion of the second loop, is called DM-20 (Quarles et al., 2006).
Myelin PLP and DM-20 are highly hydrophobic and by the addition of acyl chains their
lipophilicity is increased during their biosynthesis and transport through the cells. This
hydrophobic nature results in unusual protein properties which increase their solubility in
organic solvents such as a chloroform-methanol mixture (Weimbs and Stoffel, 1992).
Together with PLP, MBP forms the major protein in the CNS myelin (Figure 1.2). Splic-
ing of the MBP mRNA results in the production of different isoforms among which the
18.5 kDa protein is the most abundant in human. However, in rodents 18.5 kDa and 14
kDa are prominent with an increase in the ratio for 14 kDa isoform during development.
In solution, MBP has no tertiary structure, but starts to fold upon the interaction with
negatively charged membranes (Quarles et al., 2006). This protein also contains phos-
phorylation and methylation sites which might regulate its activity (Williams and Deber,
1993). Mice lacking MBP show severe abnormality in the myelin structure especially at
the end of the myelination period. The phenotype comprises severe shivering of the animal
and, therefore, is called shiverer (Chernoff, 1981).
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CNPase is mainly found in the myelin inner and outer loops and in oligodendrocyte pro-
cesses. It has two isoforms (46 and 48 kDa) in the CNS myelin that are associated with
both microtubules and microfilaments (Bauer et al., 2009). In CNPase-deficient mice
myelination appears normal, however, axonal swelling and neurodegeneration occurs in
the adults (Lappe-Siefke et al., 2003).
CNS myelin includes several glycoproteins among which MAG and MOG (myelin oligo-
dendrocyte glycoprotein) are most well-documented. MAG is a 100 kDa glycoprotein and
is present in the CNS and PNS. It is a single transmembrane protein with a highly N-
glycosylated extracellular domain. This protein is restricted to the periaxonal surface and
plays a role in the adhesion and signal transduction between glia and axonal membrane.
Although, MAG knockout mice produce myelin normally, they develop periaxonal and
paranodal structural deficiencies (Li et al., 1994). MOG, another myelin glycoprotein,
contains a single transmembrane domain with one N-glycosylation site on the extracellu-
lar domain. This protein appears on the most outer layer of the myelin structure and is
considered as a major target antigen in multiple sclerosis (Bernard et al., 1997; Quarles
et al., 2006). Another myelin glycoprotein is OMgp (oligodendrocyte myelin glycoprotein)
which is a phosphatidylinositol-linked membrane protein and has a molecular weight of
120 kDa. This protein plays a role in cell-cell interaction and inhibits axonal regeneration
(Baumann and Pham-Dinh, 2001; Quarles et al., 2006).
Other myelin proteins are mainly the members of four membrane-spanning proteins such
as MAL, plasmolipin, OSP/claudin 11, CD9 and connexins. MAL and plasmolipin are as-
sociated with glycosphingolipid-enriched membrane domains (Magyar et al., 1997; Frank,
2000; Erne et al., 2002), whereas OSP/claudin 11 is found in paranodal region and is
involved in myelin radial component formation. In addition, CD9 is important in estab-
lishment of paranodal regions since the mice deficient for this protein develop myelin with
abnormal paranodal loops (Ishibashi et al., 2004).
1.1.2.2 Myelin lipids
Myelin includes various types of lipids such as phospholipids, cholesterol and glycosphin-
golipids (GSLs) among which the last two are the main types and together compose 58% of
the total myelin lipids (Jackman et al., 2009). The distribution of lipids in the myelin bi-
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Figure 1.2: The organization of myelin compact area. PLP and MBP are the main proteins
in myelin compact area. The lipids are distributed to this region asymmetrically. The figure is
adapted from Aggarwal et al. (2011a). Reprint by permission from Elsevier Ltd: Trends in Cell
Biology, copyright (2011).
layer is asymmetric (Figure 1.2). Whereas, ethanolamine plasmalogen, phosphatidylserine
and phosphatidylinositol 4,5-bisphosphate are mainly located in the cytoplasmic leaflet,
cholesterol, galactocerebrosides and phosphatidylcholine are enriched in the extracellular
side (Quarles et al., 2006; Aggarwal et al., 2011a).
The main glycolipids in myelin are galactocerebrosides which include galactosylceramide
(GalC) and its sulfate-derivative sulfatide. GalC is produced by addition of UDP-galactose
to ceramide which is enzymatically catalyzed by UDP-galactose:ceramide galactosyltrans-
ferase (CGT). Addition of sulfate to GalC by the cerebroside sulfoteransferase (CST)
enzyme produces sulfatide (Jackman et al., 2009). Studies based on antibody reactivity as
well as mouse genetics have provided evidence for the role of these lipids in the formation
and maintenance of myelin (Dupree et al., 1998). In cgt-null mice the velocity of nerve
conduction is severely reduced to the level of unmyelinated axons. These mice develop
body tremor and abnormal locomotor activity which finally leads to death at the end of
myelination time. Moreover, disruption in paranodal junction and age-dependent neuro-
logical abnormalities have been reported in this mutant (Bosio et al., 1996). Interestingly,
cst-null mice exhibit similar phenotype as cgt-null. Both mutants contain low levels of
axonal Caspr, contactin and paranodal NF-155 in glia (Schafer et al., 2004). This indi-
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cates a role for GalC and sulfatide in the stabilization of axon-glia interaction in paranodal
regions and their involvement in supporting the stability and long-term integrity of myelin
membrane (Jackman et al., 2009; Aggarwal et al., 2011a).
Gangliosides are present as a minor type of lipids in the adult myelin. They are produced
by transforming ceramide to glucocerbroside using the enzyme, glucosyltransferase (GlcT).
This product is then converted to lactosylceramide (lacCer) by the galactosyltransferase
(galT1). Different gangliosides are generated upon addition of sialic acid to lacCer by
sialyltransferases. The production of GM4 is, however, different and it is directly derived
from GalC by a sialyltrasnferase (Jackman et al., 2009). This lipid is the major ganglio-
side in the myelin of certain species, though GM1 is the main type in most vertebrates
(Quarles et al., 2006). Mammalian myelin contains 0.1-0.3% gangliosides. These lipids are
important in paranodal junction stability (Maier et al., 2008). The interaction between
axonal gangliosides and MAG also supports the axon-glia interaction in the paranodal area
(Jackman et al., 2009). Additionally, these lipids are considered as the main myelin lipid
antigens under pathological conditions such as Guillain-Barre´-Syndrom (Willison, 2005).
1.1.3 Oligodendrocyte development
Oligodendrocytes are the responsible cells for myelin production in the CNS. The develop-
mental steps of oligodendroglial cell lineage are tightly controlled by extrinsic and intrinsic
factors. During development, oligodendrocyte progenitors are derived from ventricular and
subventricular zones in the brain, as well as the ventral midline and dorsal origin in the
spinal cord (Miller, 1999; Thomas et al., 2000; Bradl and Lassmann, 2010). These pro-
genitors express PDGFRα (platelet derived growth factor receptor), A2B5-reactive gan-
gliosides and NG2 surface molecules as well as many specific transcription factors (TFs)
such as Nkx6.1, Nkx6.2 and Olig2. Among these, Olig2 has been found to be required for
the lineage specificity (Jakovcevski et al., 2009; Emery, 2010b,a).
After cell specification, a number of transcription factors (TFs) such as Hes5, Sox5,
Sox6, Id2 and Id4 keep the precursor cells (OPCs) in the proliferation stage and prevent
them from entering the differentiation phase (Ndubaku and De Bellard, 2008; Emery,
2010a; Miron et al., 2011). Oligodendrocyte expansion is also promoted by growth fac-
tors and chemokines like FGF2 (fibroblast growth factor), PDGF-A, neuregulin 1, bFGF,
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neurotrophin-3 (NT3) and CXCL1 (chemokine (C-X-C motif) ligand 1) (Barres et al.,
1992; Miller, 2002). Among these cues, the proliferative effect of PDGF on OPCs is
well documented. PDGF is secreted by neurons and astrocytes and activates p27kip1, a
molecule which enhances proliferation by inhibiting the cell-cycle regulator cyclin-dependent
kinase 2 (cdk2) (Casaccia-Bonnefil et al., 1997).
Independent of their place of origin, OPCs have to travel through the brain and spinal
cord to reach their final place of destination (De Castro and Bribia´n, 2005). This pro-
cess is regulated by molecules from the surrounding environment. Some of the identified
molecules responsible for contact-mediated migration of OLs are tenascin-C, PSA-NCAM,
and ephrins. The OLs motility is also controlled by secreted factors such as FGF-2, PDGF,
EGF (epidermal growth factor), HGF (hepatocyte growth factor), netrins and CXCL1
(Barres et al., 1992; Miller, 2002; De Castro and Bribia´n, 2005). In general, OPCs migra-
tion regulatory molecules include chemoattractant (PDGF and semaphorin 3F), chemore-
pellants (netrins, semaphorin 3A and ephrins) and cues to stop motility (CLCX-1 and
tenascin-C) (McTigue and Tripathi, 2008; Miron et al., 2011).
The final population of OLs is determined by a balance between their proliferation and
the programmed cell death. Two major signals for oligodendrocyte survival are PDGF
and insulin-like growth factors (IGFs) (Barres et al., 1992; Miller, 2002). From these,
IGF-1 increases OL survival through the Akt signalling pathway (Flores et al., 2008).
Furthermore, Heregulin, belonging to the neuregulin family, activates Akt through erbB
receptors. Akt signalling then induces the phosphorylation of the pro-apoptotic molecule
BAD (Bcl-2-associated death promoter) and consequently enhances OL survival (Flores
et al., 2000). Indeed, the main sources of oligodendrocyte survival are neuronal signals,
which modulate the proper number of OLs required for myelination (Bozzali and Wrabetz,
2004).
Oligodendrocyte differentiation is a complex procedure that is mainly regulated by intrin-
sic factors. This process depends on the inactivation of many TFs which have inhibitory
effects on the OL terminal differentiation (Emery, 2010a). On the contrary, the activity
of other TFs such as Sox9, Sox10, Nkx2.2 and Olig1 is necessary for OPC differentiation
(Ndubaku and De Bellard, 2008; Miron et al., 2011). Also, the expression of cell surface
receptors such as GPR17, which inhibit myelination process, need to be down-regulated
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Figure 1.3: Oligodendrocyte development. Oligodendrocytes are derived from precursor cells
(OPC) which are specified from neural stem cells. Proliferating OPCs then undergo differenti-
ation to produce premyelinating oligodendrocytes. Finally, these cells become myelinating glia
in response to microenvironmental signals. In each stage cells express different markers. The
figure is adapted and modified from Nishiyama et al. (2009). Reprint by permission from Nature
Publishing Group Ltd: Nature Reviews Neuroscience, copyright (2009).
(Chen et al., 2009).
As OLs enter terminal differentiation, they produce large amounts of myelin membrane.
This stage is mainly regulated by extrinsic factors such as Lingo-1 (Leucine-rich repeat and
immunoglobulin-like domain-containing nogo receptor-interacting protein-1) and PSA-
NCAM (Rosenberg et al., 2007). Interestingly, myelin itself also inhibits the maturation of
OLs (Miller, 1999). This suggests that the communication between OLs prior to myelina-
tion might be a mechanism to coordinate their process branching (Rosenberg et al., 2007)
(Figure 1.3).
MicroRNAs (miRNAs) are small non-coding RNA molecules which post-transcriptionally
suppress the expression of their target RNAs. These small RNAs are involved in the regula-
tion of oligodendrocyte proliferation and differentiation as well as the myelin maintenance
(Dugas and Notterpek, 2011). The main reported miRNA involved in the proliferation
stage is miR-17-92 cluster. The miR-19b member of this cluster activates Akt phos-
phorylation through inhibition of PTEN activity and enhances cell proliferation in vitro
(Budde et al., 2010). Several miRNAs, including miR-219, miR-338, miR-23a, miR-23b
and miR-138, are involved in the regulation of OL differentiation (Dugas and Notterpek,
2011). From these, miR-219 suppresses PDGFRα and the transcription factors Sox6, Hes5,
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ZEP238 and FOXJ3 (Dugas et al., 2010). miR-338 is responsible for the silencing of the
TFs Sox6, Hes5, ZEP238 and also the FGFR2 (Zhao et al., 2010). Interestingly, miR-138
promotes the expression of the genes involved in the early stage of differentiation and sup-
presses the expression of the late differentiation phase genes (Dugas and Notterpek, 2011).
1.1.4 Myelin biogenesis and assembly
In order to generate myelin segments, oligodendrocytes synthesize high amounts of lipids
and proteins. The production and assembly of these components is a complex process and
is initiated as oligodendrocytes enter terminal differentiation, where they express myelin
genes extensively. Since myelin is a polarized structure, different biosynthetic mechanisms
are involved in the regulation of its biogenesis and assembly.
One of the proposed mechanisms for the delivery of myelin components to their final
destination is membrane trafficking through the biosynthetic pathway. For instance, the
involvement of vesicle transport such as direct transport, trancytosis and regulated exo-
cytosis in PLP delivery to growing membrane has been described (Kra¨mer et al., 2001;
Maier et al., 2008). Neuronal signals have been found to induce the incorporation of PLP
into myelin by an increase of cAMP levels and protein kinase A (PKA) activity (Anitei
and Pfeiffer, 2006; Trajkovic et al., 2006).
Although the majority of myelin components are delivered via vesicle trafficking, the incor-
poration of MBP and MOBP into myelin occurs differently. These proteins reach myelin
by transportation of their mRNA as granules to the myelin processes where they can be
locally translated (Simons and Trotter, 2007). The formation of these granules is regulated
by hnRNPs and they are transported via microtubules (Maier et al., 2008; White et al.,
2008; Bauer et al., 2009; White et al., 2011).
1.1.5 Axon-glia communication
The reciprocal communication between oligodendrocytes and neurons is critical for the co-
ordination of myelination in the CNS (Simons and Trajkovic, 2006). It has been reported
that glial cells are recruited to differentiate into myelinating cells upon receiving neu-
ronal signals which are quantitatively related to the axonal size (Nave and Trapp, 2008).
Neurons influence the developmental stages of oligodendrocytes to develop into myelinat-
ing cells. In turn, oligodendrocytes produce myelin to enable the saltatory conduction of
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action potentials and support long-term integrity of neurons (Simons and Trajkovic, 2006).
The regulatory function of neuronal extrinsic cues during myelination is important from
two perspectives. They regulate the precise timing of oligodendrocyte differentiation to
ensure the myelination of proper axons at the right time (Barres and Raff, 1999). For
instance, neurons release Notch ligands to inhibit OL differentiation and myelination be-
fore the proper time for myelination (Barres and Barde, 2000). In addition, they control
the final population of the myelinating oligodendrocytes by producing limited survival
signals such as neuregulin (Fernandez et al., 2000). Many neuronal-derived growth and
trophic factors such as PDGF-A, IGF-1, NT-3, FGF2 and CNTF (ciliary neurotrophic
factor) have been reported to influence oligodendrocytes development. Neuregulins are
neuron-derived proteins that activate the erbB family receptors in oligodendrocytes. In
erbB2-deficient mice a failure in oligodendrocyte terminal differentiation and thereby ax-
onal ensheathment has been shown (Park et al., 2001). Neuronal electrical activity also
promotes myelination in the CNS by inducing the neuronal secretion of promyelinating
cues like adenosine (Ishibashi et al., 2006; Demerens et al., 1996). This electrical activity
also alters the expression pattern of axonal surface proteins such as PSA-NCAM (Coman
et al., 2005) which is down-regulated prior to myelination (Charles et al., 2000). Neuronal
signals may also regulate myelin biogenesis and assembly, by influencing vesicle trafficking
in oligodendrocytes (Anitei and Pfeiffer, 2006; Trajkovic et al., 2006).
On the contrary, myelin regulates the axonal diameter by biochemical alteration of the
neuronal cytoskeleton, mainly by accumulation and phosphorylation of neurofilaments
(Quarles et al., 2006; McTigue and Tripathi, 2008). OLs also release trophic factors to
sustain axonal survival, mediated by PI3K-Akt signalling cascade (Wilkins et al., 2003;
Sherman and Brophy, 2005; Franklin and Kotter, 2008). This is supported by the finding
that oligodendrocyte-derived IGF1 and GDNF (glial cell line-derived neurotrophic factor)
promote axonal survival and outgrowth in cell culture, respectively (Wilkins et al., 2003;
Franklin and Ffrench-Constant, 2008).
1.1.6 Myelin pathology
Myelin pathology can be induced by gene mutations or inflammatory immune responses
targeting myelin and oligodendrocytes (Franklin and Ffrench-Constant, 2008). For ex-
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ample, Pelizaeus-Merzbacher disease (PMD) and X-linked spastic paraplegia (SPG2) are
abnormalities related to mutations in the plp gene (Griffiths et al., 1998a; Readhead et al.,
1994). On the other hand, multiple sclerosis (MS) and Guillain-Barre´-Syndrom are dis-
eases that arise from inflammatory immune responses targeting myelin in the CNS and
PNS, respectively (Quarles et al., 1990; Sospedra and Martin, 2005).
MS is an inflammatory disease of the CNS that can result in the deficiency of sensation
and motor function and lead to neurodegeneration (Sospedra and Martin, 2005). Upon
inflammation in the CNS, B cells, T cells and macrophages cross the blood brain barrier
(BBB) and enter the CNS, where they target OLs and myelin (Sospedra and Martin, 2005;
Jessen, 2004). This leads to the production of a high amount of auto-antibodies that trig-
ger the immune response against myelin structure and result in demyelination (Sospedra
and Martin, 2005).
In MS, demyelination events are followed by remyelination processes (Franklin and Ffrench-
Constant, 2008). Upon injury, activated microglia and astrocytes produce growth factors
and chemokines that recruit OPCs to the lesions (Franklin and Kotter, 2008; McTigue and
Tripathi, 2008; Fancy et al., 2011) and induce a switch from a quiescent to an activated
status in precursor cells (Franklin and Kotter, 2008). These OPCs then differentiate to
myelinating glia and produce myelin, which is thinner in comparison to the myelin formed
during development. However, with time remyelination declines in MS that primarily
results from inefficient recruitment and differentiation of oligodendrocytes. The contribu-
tion of differentiation impairment to remyelination failure seems to increase with aging
(Sospedra and Martin, 2005; Franklin and Ffrench-Constant, 2008).
1.2 Exosomes
Most cells release microvesicles into their surrounding space. These vesicles include shed-
ding vesicles, apoptotic bodies and exosomes. Shedding vesicles (SVs) or ectosomes have
diameter between 100 to 1000 nm and bleb from the plasma membrane. Their gener-
ation requires the activity of enzymes such as calpain, flippase, floppase and scrablase.
Ectosomes contain selectins, integrins and metalloproteinase (Mathivanan et al., 2010)
and include serine in their outer leaflet (Mittelbrunn and Sa´nchez-Madrid, 2012). Apop-
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totic bodies are heterogeneous vesicles with diameter from 50 to 500 nm and are released
during programmed cell death (Mathivanan et al., 2010). Exosomes are vesicles with di-
ameter between 40 to 100 nm and are released from many cells mainly hematopoietic,
neural, epithelial, mast and tumour cells (Piper and Katzmann, 2007; Valadi et al., 2007).
The secretion of these vesicles can be either constitutive or regulated (Lakkaraju and
Rodriguez-Boulan, 2008) and they contain proteins as well as RNAs such as mRNA and
microRNA (Valadi et al., 2007). Two proposed function for exosomes are disposal of
surplus materials and transfer signals to the target cells (Fru¨hbeis et al., 2012). The as-
sociation of exosomes with many physiological and pathological conditions highlights the
importance of these vesicles in health and disease.
1.2.1 Composition of the exosomes
Independent of their origin, all exosomes contain a specific subset of proteins such as alix,
TSG101 (tumor susceptibility gene 101), Rab GTPases, SNAREs (Soluble NSF Attach-
ment Protein Receptors) and annexins which are involved in their biogenesis, transport
and fusion (Simons and Raposo, 2009). Further components of exosomes are tetraspanins
(CD63, CD9, CD81 and CD82), adhesion molecules (MFG-E8 and integrins), heat shock
(Hsc70 and Hsc90), cytoskeletal proteins (actin, cofilin, tubulin and moesin) and raft as-
sociated proteins (flotillin, stomatin, lyn and CD55) (De Gassart et al., 2004; Fe´vrier and
Raposo, 2004; Simons and Raposo, 2009). However, depending on their origins, exosomes
may contain some specific proteins. For instance, hematopoietic cells-derived exosomes
carry antigen presenting proteins such as CD86, MHC I and II (Fe´vrier and Raposo, 2004).
Exosomes are furthermore enriched in raft-lipids, such as cholesterol, sphingolipids and
ceramide (Figure 1.4 A) (Simons and Raposo, 2009).
1.2.2 Formation and release of exosomes
Exosomes are generated from multivesicular bodies (MVBs) by inward budding of the
membranes (De Gassart et al., 2004). MVBs are a part of the endosomal system which
includes primary endocytic vesicles, early and late endosomes (EEs and LEs) as well as
lysosomes (Denzer et al., 2000). The invagination of the limiting membrane of endosomes
results in the formation of intraluminal vesicles (ILVs) of MVBs (Hurley and Hanson,
2010). These MVBs will face two different fates; fusion with the lysosmes to degrade
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Figure 1.4: Exosome composition and formation. (A) Exosomes contain many proteins in-
volved in their biogenesis and release. They also include specific lipids and carry nucleic acids.
The figure is adapted and modified from Mittelbrunn and Sa´nchez-Madrid (2012). Reprint by per-
mission from Nature Publishing Group ltd: Nature reviews molecular cell biology, copyright (2012).
(B) Exosomes are generated from inward budding of multivesicular bodies (MVBs). MVBs are a
part of the endosomal system and are generated by the invagination of late endosomes to pro-
duce intraluminal vesicles (ILVs). The figure is adapted and modified from Cocucci et al. (2009).
Reprint by permission from Elsevier Ltd: Trends in Cell Biology, copyright (2009).
their contents, and fusion with the plasma membrane to release their components into
extracellular space (Figure 1.4 B) (Denzer et al., 2000; Keller et al., 2006). Once generated,
the destination of MVBs depends on their molecular composition. For instance, ILVs
enriched in ubiquitinated proteins and phosphatidylinositol-3-phosphate are delivered to
lysosomes, whereas vesicles rich in lysobisphosphatidic acid (LBPA) may undergo non-
degradative pathway (Van Der Goot and Gruenberg, 2006; Subra et al., 2007).
The insertion of proteins into MVBs is mediated by two mechanisms; mono-ubiquitination
of target protein and non-ubiquitin sorting mechanism, which requires signals such as
tetraspanin enrichment or cholesterol enriched domains (Keller et al., 2006; Piper and
Katzmann, 2007). The insertion of ubiquitinated proteins into MVBs is carried out by
ESCRT (endosomal sorting complex required for transport) machinery which include four
complexes and some associated proteins. First, the ESCRT protein Vsp-27 identifies the
ubiquitinated cargos and then engages other ESCRT complexes as well as TSG101 to ac-
tivate AIP/Alix which inserts the target into the budding vesicles (Fe´vrier and Raposo,
2004; Johnstone, 2006; Keller et al., 2006). Alix is a linker between ESCRT complexes
and together with TSG101 is a part of ESCRT I complex (Lakkaraju and Rodriguez-
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Boulan, 2008). While ESCRT I and II recognize ubiquitinated proteins, ESCRT III is
involved in membrane budding (Simons and Raposo, 2009). Finally ESCRT complexes
release the vesicle into MVBs intraluminal space using their intrinsic budding and scission
function (Hurley and Hanson, 2010). After formation, MVBs are transported to lysosomes
or plasma membrane by the docking and fusion that is regulated by Rabs and SNAREs
(Denzer et al., 2000; Fe´vrier and Raposo, 2004). Many members of Rab GTPase family are
involved in exosomes formation and release. Whereas Rab4, Rab5 and Rab11 are involved
in early recycling endosomes, Rab7 and Rab9 participate in the formation of late endo-
somes (Mathivanan et al., 2010). From these, Rab11 induces exosomes formation in K562
(Fader et al., 2005) and their release in dendritic cells (Lakkaraju and Rodriguez-Boulan,
2008). Other Rabs involved in exosome release are Rab35, Rab27a and Rab27b (Bobrie
et al., 2011; Hsu et al., 2010). Moreover Ca2+ is also essential for exosome formation and
release (Johnstone, 2006).
1.2.3 Function of exosomes
Exosomes are involved in horizontal transfer of proteins and RNAs between cells and
therefore are considered as a novel type of communication (Valadi et al., 2007; Lai and
Breakefield, 2012). For instance, exosomes from differentiated reticulocytes and platelets
possess clearance and aggregatory function, respectively (Rabesandratana et al., 1998;
Heijnen et al., 1999). Exosomes also play a role in antigen presentation and develop-
ment of tolerance (The´ry, 2011). They might be also involved in the establishment of cell
polarity and tissue patterning (Lakkaraju and Rodriguez-Boulan, 2008). To fulfill these
functions exosomes can interact with target cells via three different mechanisms; binding
to the plasma membrane surface, fusion with the target membrane, or internalization by
the recipient cells (Denzer et al., 2000; Valadi et al., 2007). The best examples of exosomal
function have been described in antigen presentation and tumour metastasis (Lakkaraju
and Rodriguez-Boulan, 2008).
Exosomes are widely used for communication between immune cells (Keller et al., 2006).
They increase the immunological responses by inducing the activation of T cells (John-
stone, 2006). For instance, antigen presenting cells (APCs) such as B cells and dendritic
cells (DCs) release exosomes containing MHC peptides for presenting to specific T cells to
influence adaptive and anti-tumour immune responses, respectively (The´ry, 2011). The
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vesicles from dendritic cells also recruit more DCs presenting MHCs (Bobrie et al., 2011).
Several human tumours such as melanoma, colon, ovarian, breast, and prostate carcinoma
secrete exosomes. Tumour-derived exosomes affect the immune system by inducing apop-
tosis in activated anti-tumour T cells and impair dendritic cell maturation (Iero et al.,
2008). They also inactivate T cells and natural killer cells and induce differentiation of
regulator T cells or myeloid cells to suppress immune system (Bobrie et al., 2011; The´ry,
2011). In addition, tumour-derived exosomes possess self-promoting effect and induce the
proliferation of their cells of origin (Skog et al., 2008). They also contain RNAs and induce
angiogenesis in endothelial cells (Mittelbrunn and Sa´nchez-Madrid, 2012). In melanoma
patients, exosomes induce angiogenesis and metastatic invasion which produce a tumour
niche by altering ECM (Somasundaram and Herlyn, 2012).
Exosomes play a role in the nervous system during development and in disease (Lai and
Breakefield, 2012). MVBs from neurons contain mRNAs and are present in both pre- and
post-synaptic structures (Chivet et al., 2012). The functions of exosomes in the neural
system under physiological conditions include neural development (such as axon pathfind-
ing), synaptic activity (L1 and GluR2/3 containing MVBs), regeneration, and axon-glia
communication. They are also involved in pathological conditions such as neurodegener-
ative diseases (Lai and Breakefield, 2012).
Recent studies have suggested a contribution of exosomes in the progression of neurode-
generative diseases such as Alzheimer’s (AD), Parkinsons’s and ALS (amyotrophic lateral
sclerosis) diseases (Vella et al., 2008). In Alzheimer’s disease (AD), β-amyloid peptides
(Aβ) are produced by proteolytic cleavage of the amyloid precursor protein (APP) (Cai
et al., 1993). Minor fractions of Aβ have been found to be released by exosomes (Rajen-
dran et al., 2006). Accordingly, an accumulation of the exosomal proteins such as alix and
flotillin in the brain plaques from AD patients has been detected (Kokubo et al., 2000; Ra-
jendran et al., 2006). Moreover, exosomes from prion protein-expressing cells carry both
naturally (PrPc) and abnormally-folded (PrPsc) protein variants (Fevrier et al., 2004).
These proteins are involved in disorders such as CJD, GSS, BSE and scrapie (Chakraborty
et al., 2005). Interestingly, exosomes carrying PrPsc can induce the conversion of endoge-
nous PrPc to PrPsc in the non-infected target cells (Vella et al., 2007). As exosomes
circulate in body fluids such as serum, urine and CSF (Cerebrospinal fluid) and contain
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disease related proteins, they are considered as potential markers in pathological condi-
tions (Bellingham et al., 2012).
1.3 Cell adhesion and glycocalyx
1.3.1 Cell adhesion
Cell adhesion influences basic cell functions such as proliferation, survival, motility and
differentiation (Vitte et al., 2005). The adhesion between two biological membranes is
regulated by different forces including specific interaction between cell surface receptors,
non-specific or generic forces, and membrane elasticity. This dynamic process involves a
series of steps to modulate the contact between two opposite membranes. To expose the
hidden ligand and receptors from the membrane surface, the repulsive molecules, mainly
glycocalyx, should be excluded. This leads to homophilic or heterophilic interaction be-
tween cell adhesion molecules and thereby formation of a tight interacting zone, a process
involving receptor segregation. Moreover, signalling associated with adhesion event modu-
lates the long term interaction between two membranes. (Sackmann and Bruinsma, 2002).
The main specific receptors involved in adhesion process are classified into integrins, im-
munoglobulin superfamily/IgSF (NCAM, CD2 and CD58), selectins (CD62-P, CD62-E),
mucine-like molecules (leukosialin/CD43), and cadherins (Vitte et al., 2005).
1.3.2 Glycocalyx
Glycocalyx is a carbohydrate-rich layer associated with the cell membrane surface. It com-
prises of a wide variety of membrane associated macromolecules including glycoproteins,
glycolipids, and proteoglycan (Weinbaum et al., 2007; Curry and Adamson, 2011). Gly-
coproteins contain relatively short oligosaccharide chains (2-15 residues), especially sialic
acid with branched carbohydrate sequences. Major components of this group are cell
adhesion molecules and coagulation and fibrinolysis elements. Proteoglycans are proteins
with a covalently associated sulfated glycosaminoglycans (GAGs) side chain which provide
a net negative charge due to the polyanionic nature of its components. GAGs are classi-
fied into five groups; heparin sulfate (HS), keratin sulfate, dermatan sulfate, chondroitin
sulfate (CS), and hyaluronan or hyaluronic acid (Reitsma et al., 2007; Weinbaum et al.,
2007). The glycocalyx also involves soluble components that are connected to the plasma
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membrane via proteoglycans and glycoproteins (Reitsma et al., 2007). Other components
of this structure are enzymes, enzyme inhibitors, growth factors, cytokines, cationic amino
acids, and cations (Weinbaum et al., 2007). The composition and interaction of glycocalyx
elements is highly dynamic. Therefore, removal of an individual constituent of the layer
influences its properties, highlighting the importance of the interactions within the intact
architecture (Reitsma et al., 2007). Cells can modulate the glycocalyx to adjust their
adhesion under physiological state (Vitte et al., 2005). Many observations also indicate a
role for the glycocalyx in mechano-transduction. This occurs by transmitting fluid shear
stress into cells through glycocalyx components which in turn induces rearrangement of
actin cytoskeleton and generates signalling events (Tarbell and Pahakis, 2006).
1.3.3 Glycocalyx involvment in cell adhesion
Glycocalyx contains a huge density of repeller molecules, which modulate the contact be-
tween two adhering cells (Sackmann and Bruinsma, 2002). Besides the participation of
glycan structures in interaction between cells as a simple bridge, they can also regulate
adhesion by non-specific activity (Taylor and Drickamer, 2007). Living cells control their
adhesive capacity by adjusting the amount of glycocalyx, which generates non-specific
repulsion and impairs adhesion more efficiently under dynamic conditions (Sabri et al.,
1995, 2000). In the presence of glycocalyx, despite the expression of adhesion molecules
the interaction between two membranes may not occur due to negative regulation by non-
specific repulsive forces (Foa et al., 1996). Thus, relative length of adhesion elements
together with surface repeller density, are the key parameters for determination of steric
(physical) stabilization between different cells. For instance, elimination of a glycocalyx
component, CD43, from THP-1 cells membrane surface, increases their adhesiveness under
physiological condition, which might be an expedient way for cells to induce rapidly the
activity of many existed receptors on their membranes (Foa et al., 1996; Sabri et al., 2000).
Furthermore, glycocalyx attenuates the interaction between blood cells and vessel wall.
It also prevents the interaction of platelets to endothelium under physiological condition,
whereas partial removal of glycocalyx increases platelet adhesion to vessel wall (Reitsma
et al., 2007).
The pericellular matrix is composed of a variety of carbohydrates that include anionic
groups such as sialic acid and sulfate group which consequently give the living cells a net
negative charge surface. This electrically charged cell-coat produce a dynamic repulsive
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barrier preventing cell-cell interaction efficiently (Sabri et al., 1995). The steric repulsion
relies on the ionic strength. The restoring of the inhibitory effect on the cell interaction
by monovalent salt indicates the involvement of negative charge in the contact process
(Johnson et al., 2005). For example, endothelial glycocalyx permeability is dependent
on size, steric hindrance, and electrostatic charge. An increase in albumin uptake and
labeled dextran internalization has been reported upon neutralization of the glycocalyx,
underscoring the involvement of electrostatic charges in the process (Reitsma et al., 2007).
1.3.4 Sialic acid and its polymer PSA
It has been proposed that sialic acid is the main molecule to prevent the intermembrane
contact by steric inhibition (Fujimoto et al., 2001). Consistent with this hypothesis the
electrostatic repulsion from this molecule, incorporated into glycoproteins, induces the
separation of endothelial cell surface and thereby lumen formation. This mechanism may
apply to initiate lumen development in other organs (Strilic´ et al., 2010). However, the
main form of sialic acid, which is involved in preventing membrane adhesion, is polysialic
acid (PSA). PSA is a long, negatively charged, linear carbohydrate polymer which is
produced by α2,8-linked interaction between N-acetylneuraminic acid (Neu5Ac) residues.
This linear polymer is post-translationally attached to proteins such as NCAM (Johnson
et al., 2005). The regulatory function of PSA on membrane adhesion is dependent on
its abundance, massive volume in hydrated form, and slippery nature. This sialic acid
polymer has been shown to have a direct effect on distance between membranes by gen-
erating a physical repulsion rather than a receptor binding activity (Rutishauser, 2008).
Moreover, PSA influences the adhesion properties of other proteins in the membrane sur-
face. This effect is a general characteristic of PSA rather than the interfering with a
specific interaction (Taylor and Drickamer, 2007). The biological function of adding PSA
to NCAM has been revealed to influence global cell interaction rather than NCAM ac-
tivity (Fujimoto et al., 2001). On the other hand, the main function of polysialylation is
to prevent NCAM-mediated adhesion that consequently inhibits the interaction between
other protein receptors due to large volume of hydrated PSA (Taylor and Drickamer,
2007; Rutishauser et al., 1990). For instance, the cadherin-dependent adhesion has been
reported to be attenuated upon increase in the ratio of PSA-NCAM to this protein (John-
son et al., 2005).
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1.4 Aims of the study
Exosomes are microvesicles which are considered as a novel system for cell communica-
tion. Oligodendrocytes, as the myelinating cells in the central nervous system, are known
to produce exosomes. The function of these vesicles in oligodendrocytes, however, has
not been elucidated yet. In the first part, we investigated the role of oligodendrocyte-
derived exosomes during axon-glia interaction in a cell culture model system. We also
studied the molecular mechanisms used by these vesicles to exert their effect. Moreover,
we explored the possible regulatory effect of neuronal signals on exosomes release by oligo-
dendrocytes. The answers to these questions could provide evidence for the physiological
role of oligodendrocyte-derived exosomes in the CNS.
In the second part, we investigated the mechanisms involved in the adhesion and com-
paction in the extracellular leaflets of the myelin membrane. We explored the putative role
of proteolipid protein (PLP) in the adhesion of myelin extracellular side. We also analyzed
glycocalyx alteration during oligodendrocyte maturation and investigated whether the re-
moval of this carbohydrate-rich layer influences myelin adhesiveness. Addressing these
questions might provides more insight into the assembly and stability of myelin membrane
structure in the central nervous system.




2.1.1 Chemicals and consumables
All the chemicals were purchased from Sigma-Aldrich GmbH (Munich, Germany), Ap-
pliChem GmbH (Darmstadt, Germany) or Merck KGaA (Darmstadt, Germany) unless
stated. All media, supplements, antibiotics and sera for cell culture were obtained from
PAA Laboratories GmbH (Pasching, Austria) or Gibco/Invitrogen GmbH (Darmstadt,
Germany). The consumable materials for cell culture, biochemical analysis, and molecu-
lar biology were supplied by Eppendorf AG (Hamburg, Germany), Falcon (Becton Dick-
inson Labware Europe, Le Pont De Claix, France) and Greiner Bio-One (Greiner Bio-One
GmbH, Frickenhausen, Germany). The tubes for ultracentrifugation were purchased from
Beckman (Beckman Coulter GmbH, Krefeld, Germany).
The chemical components and inhibitors listed in table 2.1 were purchased from Sigma-
Aldrich, Munich, Germany.
Table 2.1: Inhibitors and chemical components
Name Application Solvent
Y27632 10 µM DMSO
Belbbistatin 50 µM DMSO
PP2 1 µM DMSO
Dextran 5 mg/mL Water
Dextran sulfate 5 mg/mL Water
Protamine sulfate 50 µg/mL Water
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2.1.2 Antibodies and labeling components
Primary antibodies which are listed in table 2.2 were used in this study. Biotinylated
Maachika amurensis lectin II (MAL II) were obtained from Vector lab., Burlingame, CA,
USA.
Table 2.2: Primary antibodies
Target Host species “Application”1 Resource
A2B5 Mouse IgM IF (1:200) Millipore
Actin (AC-40) Mouse IgG2a WB (1:500) Sigma-Aldrich
Akt (pan) Rabbit WB (1:1000) Cell Signaling
Akt (p-Ser-473) Rabbit WB (1:1000) Cell Signaling
Alix/AIP Mouse IgG1 WB (1:1000) BD Biosciences
Calnexin Rabbit WB (1:1000) Stressgen Bioreag.
CNPase Mouse IgG1 IF (1:200), WB (1:500) Sigma-Aldrich
FAK Mouse IgG1 WB (1:1000) BD Transd. Lab.
FAK (p-Tyr-397) Rabbit WB (1:!000) Invitrogen GmbH
Flotillin-2 Mouse IgG WB (1:1000) BD Biosciences
Fyn (H-80) Rabbit WB (1:200) Santa Cruz Biot.
GFAP Mouse IgG IF (1:100) Santa Cruz Biot.
Iba1 Rabbit IF (1:200) Wako Chem. GmbH
MAG (clone 513) Mouse IgG1 WB (1:500) (Poltorak et al., 1987)
MBP Mouse IgG1 IF (1:1000) Sternberger
MBP Rabbit IF (1:400), WB (1:1000) DakoCytomat.
MLC2 Rabbit WB (1:1000) Cell Signaling
MLC2 (p-Ser-19) Rabbit WB (1:1000) Cell Signaling
MOG (clone 8-18-C5) Mouse IgG1 IF (1:100), WB (1:500) Millipore
Myc Rabbit IgG IF (1:500) Sigma-Aldrich
NogoA (11C7) Mouse IgG WB (1:10000) From M. Schwab
O1 Mouse IgM IF (1:50), DB (1:100) (Sommer and Schachner, 1981)
O4 Mouse IgM IF (1:50) (Kuhlmann-Krieg et al., 1988)
PLP (clone 3F4) Mouse IgG WB (1:100) (Greer et al., 1992)
PLP (P6) Rabbit IF (1:300) (Linington and Waehneldt, 1990)
PLP (AA3) Mouse IgG WB (1:150) Clone from K. Nave
RhoA Rabbit WB (1:1000) Cell Signaling
Ribosomal S6 (p-Ser-235/236) Rabbit WB (1:1000) Cell Signaling
SFK (p-Ty r-529) Rabbit WB (1:1000) Calbiochem/Merck KGaA
SFK (p-Tyr-418) Rabbit WB (1:1000) Calbiochem/Merck KGaA
ST8SIA4 Rabbit WB (1:1000) Sigma-Aldrich
TSG-101 Mouse IgG1 WB (1:1000) GeneTex Inc.
Tubulin, β-III Mouse IgG1 IF (1:3000) Promega
1IF: immunocytochemistry, WB: western blot, DB: dot blot
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The secondary antibodies and fluorophore-coupled compounds used in this study are listed
in table 2.3.
Table 2.3: Secondary antibodies and fluorophore-coupled compounds
Name Obtained from
HRP-anti mouse IgG Dianova, Hamburg, Germany
HRP-anti mouse IgM Dianova, Hamburg, Germany
HRP-anti rabbit Dianova, Hamburg, Germany
Alexa Fluor 488 anti rabbit Invitrogen GmbH,Darmstadt, Germany
Alexa Fluor 488 anti mouse IgG Invitrogen GmbH, Darmstadt, Germany
Alexa Fluor 488 anti mouse IgM Invitrogen GmbH, Darmstadt, Germany
Cy3 anti mouse IgG Dianova, Hamburg, Germany
Cy3 anti mouse IgM Dianova, Hamburg, Germany
Cy5 anti mouse IgG Dianova, Hamburg, Germany
Cy5 anti rabbit Dianova, Hamburg, Germany
DyLight anti rabbit IgG Dianova, Hamburg, Germany
Alexa Fluor 647 anti mouse IgG Invitrogen GmbH, Darmstadt, Germany
Alexa Fluor 488 streptavidin Invitrogen GmbH, Darmstadt, Germany
Alexa Fluor 647 ConA Invitrogen GmbH, Darmstadt, Germany
Cell mask orange Invitrogen GmbH, Darmstadt, Germany
2.1.3 Commercial kits
The commercial kits used in this investigation are listed in table 2.4.
Table 2.4: Commercial kits
Kit Application Producer
BrdU in situ detection kit Cell proliferation BD Biosciences
ConA isolation kit Glycoprotein isolation Thermo scientific
Fluorescein lectin kit I Lectin staining Vector lab.
PKH26 Red Fluorescent Cell Linker General Cell Membrane Labeling Sigma-Aldrich
PKH67 Green Fluorescent Cell Linker General Cell Membrane Labeling Sigma-Aldrich
Rhotekin RBD, agarose RhoA-GTP pull-down Millipore
Click-iT® Cell Reaction Buffer Kit Metabolic labeling Invitrogen GmbH
2.1.4 Animals
The following mouse and rat strains were utilized in this study.
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Table 2.5: Mouse and rat strains
Strain Genetic alteration Origin
NMRI WT mice No mutation Animal core facility, MPI of Experimental Medicine
C57/N WT mice No mutation Animal core facility, MPI of Experimental Medicine
KPLP mice PLP knockout K.-A. Nave (Klugmann et al., 1997)
Shiverer mice MBP knockout (Chernoff, 1981)
PLP-PST (tg246) ST8SiaIV overexpression M. Eckhardt (Fewou et al., 2007)
WT Rat No mutation Animal core facility, MPI of Experimental Medicine
2.1.5 Plasmids
The following expression plasmids which have been previously published, were used: PLP-
myc from Trajkovic et al., 2006, pcDNA3.1-S-MAG N ter (truncated) and pcDNA3.1-S-
MAG N terC36 (full length) from Aggarwal et al., 2011b.
2.1.6 Media and sera
2.1.6.1 Commercial media, sera and solutions
Table 2.6: Commercial media, sera and solutions
Media, sera, and solution Manufacturer
B-27 supplement Gibco/Invitrogen GmbH, Darmstadt, Germany
Basal Medium Eagle (BME) Gibco/Invitrogen GmbH, Darmstadt, Germany
Dulbecco’s Modified Eagle Medium (DMEM) Gibco/Invitrogen GmbH, Darmstadt, Germany
Dulbecco’s Modified Eagle Medium (DMEM) PAA Laboratories GmbH, Pasching, Austria
Fetal Calf Serum (FCS) PAA Laboratories GmbH, Pasching, Austria
GlutaMAX™ supplement Invitrogen GmbH, Darmstadt, Germany
HEPES buffer AppliChem GmbH,Darmstadt, Germany
Horse Serum (HS) PAA Laboratories GmbH, Pasching, Austria
Insulin-Transferrin-Selenium - A supplement 100× Invitrogen GmbH, Darmstadt, Germany
LB medium and LB agar plate AppliChem GmbH, (Darmstadt, Germany
L-Thyroxine Calbiochem/Merck KGaA, Darmstadt, Germany
Opti-MEM + GlutaMAX™ Invitrogen GmbH, Darmstadt, Germany
Phosphate Buffered Saline (PBS) PAA Laboratories GmbH, Pasching, Austria
Penicillin/Streptomycin (Pen/Strep) 100× Invitrogen GmbH, Darmstadt, Germany
Sodium Pyruvate Gibco/Invitrogen GmbH, Darmstadt, Germany
Triiodothyronine Calbiochem/Merck KGaA, Darmstadt, Germany
Trypsin-EDTA Gibco/Invitrogen GmbH, Darmstadt, Germany


























Adobe Illustrator CS 3 Adobe Systems Incorporated,California, USA
GraphPad Prism GraphPad Software, Inc., California, USA
ImageJ http://rsbweb.nih.gov/ij/
Leica Confocal Software, 2.61 Leica, Mannheim, Germany
Meta Imaging Series 6.1 Universal Imaging Corp., USA
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2.2 Methods
2.2.1 Cell culture and transfection
2.2.1.1 Primary culture
Primary cultures of rat or mouse oligodendrocytes from postnatal day 1 were prepared as
described previously (Trajkovic et al., 2006). Neonatal brain hemispheres were stripped
free of meninges, digested and cultured in Eagle ’s basal medium with 10% horse serum
on poly-L-lysine-coated flask at 37 °C. After 8-10 days, oligodendrocytes were harvested
from mixed glia culture using mechanical dissociation. Isolated cells were then cultured
in DMEM containing B-27 supplement, 1% horse serum, triiodothyronine, L-thyroxine,
pyruvate, glutamine, and penicillin/streptomycin on poly-L-lysine-coated glass coverslips
or dishes.
Microgilal and astrocyte cells were isolated from the same mixed glia culture, used for
OLs purification. After 10 days of culture and removing of oligodendrocytes, the remain-
ing cells were trypsinized and plated on poly-L-lysine-coated glass coverslips in DMEM
containing 10% FCS, glutamine, and penicillin/streptomycin. After 3 days, the cells were
used for further analysis.
Primary neuronal cultures were obtained by preparing a mixed brain culture from E16
(embryonic day 16) mice (Fitzner et al., 2006). The cells were plated and cultured for
2 weeks in super sato medium. The neuronal conditioned medium was obtained from
these cultures, collected after culturing for 2 weeks, centrifuged for 10 min at 1,500 rpm,
and used. Coculture of neurons and oligodendrocytes were prepared by adding of 30,000-
50,000 OLs to 2 week old neuronal cells cultured on coverslips.
2.2.1.2 PtK2 cells
The cells were maintained in DMEM medium with 10% FCS in flasks with regular passag-
ing (Eggeling et al., 2009). For experimental procedure, cells were trypsinized and then
plated on glass coverslips. After obtaining desired confluency, cells were used for assays.
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2.2.1.3 Transfection
Primary oligodendrocytes transfection was performed using lipofectamine transfection
reagent (Gibco/Invitrogen GmbH, Darmstadt, Germany). 1.6 µg of plasmid DNA and
4 µl of lipofectamine were added to 100 µl Opti-MEM separately and incubated for 5 min
at room temperature. The fractions were then mixed and incubated further for 25 min
and then added to 4-day-old primary oligodendrocytes for 16 hr.
For PtK2 cell line, Trans-IT transfection reagent (Mirus Biologicals LLC, Madison, WI,
USA) was applied to deliver mammalian expression vector into the cells. The cells were
cultured till 60-75% confluency on the day of transfection. 3 µl of transfection reagent
and 1 µg of plasmid DNA were added subsequently to 100 µl Opti-MEM and the mixture
was incubated at room temperature for 25-35 min. The mixture was then introduced to
the cells with gentel shaking and the cells were incubated further for 16 to 24 hr.
2.2.2 Exosomes Preparation
Exosomes were prepared using differential centrifugation steps (Hsu et al., 2010) which
were carried out by a Beckman XL-70 Ultracentrifuge (Beckman Coulter GmbH, Krefeld,
Germany). After 6 to 8 day of OLs culturing, the medium was collected, and then cen-
trifuged for 10 min at 3,000 × g and two times for 10 min at 4,000 × g before subjecting it
for ultracentrifugation at 10,000 × g for 30 min and at 100,000 × g for 1 hr. The collected
pellets were finally resuspended in PBS, medium or sample buffer.
2.2.3 Proliferation assay
Proliferation of OLs was assessed using BrdU in situ detection kit. Briefly, one day after
shaking, OLs were incubated with 10 µM Bromodeoxyuridine (BrdU) and proliferation
assay was performed after 24 hr. Cells were fixed, washed in PBS, and permeabilized.
After blocking of endogenous peroxidase activity, cells were incubated with biotinylated
anti-BrdU antibody, washed in PBS, followed by incubation with Streptavidin-HRP. The
samples were then subjected to BAD substrate for 5 min to develop the desired colour
intensity. After washing, cells were stained for A2B5 antibody as an oligodendrocyte pro-
genitors marker. BrdU incorporation was defined as the percentage of A2B5-positive cells
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that were positive for BrdU.
2.2.4 RhoA activity measurements
RhoA activity was evaluated by affinity precipitation of active Rho (GTP-bound). Oligo-
dendroglial cells were cultured for 4 days and RhoA activity was measured using Rho
assay reagent. Cells were lysed (Mg2+ lysis/wash buffer with “Complete” protease in-
hibitor cocktails) according to the manufacturer’s instructions. After removing of the cell
debris, the lysates were incubated with Rho assay reagent, which specifically binds to
the active form of Rho (Rho-GTP), for 45 min at 4 °C. Beads were then washed 3 times
with Mg2+ lysis/wash buffer and once with PBS. The final pellets were then resuspended
in sample buffer, boiled for 10 min, and subjected to 12% SDS-PAGE for western blot
analysis using anti-RhoA antibody.
2.2.5 Protein biochemistry
2.2.5.1 Preparation of cell lysates
Oligodendrocytes were cultured in PLL-coated dishes for few days. After removing the
culture medium, cells were washed with PBS and scraped on ice into lysis buffer (2% NP-
40, 0.2% SDS, 1 mM EGTA in PBS supplied with “Complete” protease and phosphatase
inhibitor cocktail from Roche) or (100 mM Tris-HCl, pH 7.5, 300 mM NaCl, 2 mM EDTA,
2% Triton X-100 supplied with “Complete” protease and phosphatase inhibitor cocktails).
The lysates were centrifuged at 10,000 g for 10 min. The protein concentration was
determined using Bradford assay. A fraction of the supernatant was mixed with the same
amount of sample buffer (20% glycerol, 4 mM EDTA, 4% SDS, 4% 2-mercaptoethanol,
0.05% Bromophenol blue and 100 mM Tris-HCl pH 6.8) and kept at -20 °C for further
analysis. For p-SKF, Fyn and FAK analysis, cells were lysed using the RIPA buffer (10 mM
Tris-HCl pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM Na4P2O4,
2 mM Na3VO4, 0.1% SDS, 0.5% Sodium deoxycholate, 1% Triton X-100 supplied with
“Complete” protease and phosphatase inhibitor cocktails).
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2.2.5.2 SDS-PAGE
Sodium dodecyl sulfate ployacrylamide gel electrophoresis (SDS-PAGE) was performed
under denaturing condition to analyse proteins expression and modification. Using a Bio-
Rad Mini-PROTEAN 3 casting system, a two-layer (resolving and stacking) gel was set
up with the folowing components:
Stacking gel
4% Acrylamide/bis-acrylamide (37.5:1) solution
125 mM Tris-HCl pH 6.8
0.1% SDS
0.05% Ammonium persulfate (APS)
0.005% (v/v) N,N,N’,N’-Tetramethylethylene-diamine (TEMED)
Resolving gel (8-15%)
8-12% Acrylamide/bis-acrylamide (37.5:1,w:w) solution




Separation of protein samples was performed in vertical electrophoresis systems in Tris-
glycine electrophoresis buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) for 1 hr at 100
V.
2.2.5.3 Western Blot
After separation with SDS-polyacrylamide gels, the proteins were transferred to a nitro-
cellulose membrane (Whatman GmbH, Dassel, Germany) using the Bio-Rad Mini-Protein
System. The transfer procedure was carried out for 1 hr at 100 V in a transfer buffer
(25 mM Tris, 192 mM glycine, 20% methanol). After transferring, the membranes were
incubated in blocking solution (5% skim milk powder in PBS) for 30 min at room temper-
ature and afterward incubated with primary antibody in PBST (0.1% Tween-20 in PBS)
at 4 °C overnight. After washing 3 ×5 min at RT with PBST, the membranes were in-
cubated with the appropriate secondary antibodies conjugated to horseradish peroxidase
(HRP) for 40 min at RT, and washed again 3 ×5 min at RT with PBST. The proteins
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were detected by enhanced chemiluminescence (Pierce/Thermo Scientific) and bands were
quantified using ImageJ Software.
2.2.6 Myelin membrane analysis
2.2.6.1 Myelin preparation
The Preparation of myelin membrane was performed as described (Larocca and Norton,
2007) previously. The brains from 2 to 6-month-old mice were homogenized in 0.32 M
sucrose solution (containing 5 mM EDTA, 10 mM HEPES pH 7.4 and protease inhibitors)
by tip sonication. The homogenates were applied to a two-step sucrose gradients (0.32 M
and 0.85 M sucrose in HEPES-EDTA buffer). The gradients were centrifuged at 74,000 ×
g for 30 min, and the interfaces (crude myelin) were collected, diluted with H2O and cen-
trifuged at 74,000 × g for 15 min. The pellet fraction was washed twice with ice-cold H2O
and recovered by 10 min centrifugation at 12,500 × g and the procedure was repeated
further to obtain purified myelin. The pure myelin fraction was resuspended in HEPES-
EDTA buffer and stored at -20 °C for further analysis.
2.2.6.2 Myelin particles preparation
Myelin particles were purified using ConA glycoprotein isolation kit. A fraction of myelin
membrane was washed and resuspended with H2O. After passing through 27-gauge needle
and sonication for 3 min, the myelin membrane was then applied to ConA beads for 30
min at RT. The flow through was collected using centrifugation at 1,000 × g for 1 min.
To remove MBP from particles, they were resuspended in the following buffers with ratio
2:1; 10 mM Tris-HCl pH 7.4 and 450 mM Tris-HCl pH 7.4, 6 mM CaCl2, 6 mM MgCl2,
for 3 hr at 37 °C with gentle shaking (Glynn et al., 1987; Earl et al., 1988). The final
pellet was resuspended in PBS and kept at 4 °C for further analysis.
2.2.6.3 Myelin particles labelling and binding assay
Purified myelin particles were fluorescent labeled using two lipophilic dyes (PKH26; red
and PKH67; green). Breifly, 100 µl of myelin particles were mixed with 900 µl of diluent
C and 1 µl of PKH dyes. The mixture was vigorously vortexed and incubated for 5 min
at RT. 200 µl of FCS was added to the samples to stop the reaction and the mixture was
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Figure 2.1: Myelin particle preparation and labeling. Preparation and labeling of particle from
purified myelin membrane is presented.
applied to centrifugation for 10 min followed by washing twice with PBS. The final pellet
was resuspended in the cell medium and kept at 4 °C (Figure 2.1).
For binding assay, 100 µl of labelled particles were added on top of the cells cultured on
coverslips. The binding procedure was carried out for 30 min at 37 °C and the cells were
directly fixed and processed for immunolabeling. Using confocal imaging the number of
myelin particles per cell area was calculated.
2.2.7 Lectin staining
All the lectins were obtained from Vector laboratories. Fixed cells were incubated with
5-10 µg/ml lectins for 10 min at RT and then mounted on glass slides. For MAL II
lectin staining, cells were incubated with 10 µg/ml biotinylated MAL II for 30 min at RT,
followed by washing with PBS and incubating with fluorescent-streptavidine for 10 min
before mounting.
Brain sections prepared by free-floating approach were incubated with 15 µg/ml MAL II
at 4 °C overnight. The samples were then stained by fluorescent-streptavidine for 5 hr at
RT and mounted. For WGA staining, sections were incubated with 10 µg/ml fluorescent-
lectin for 5 hr at RT before mounting. The brain slices were also co-stained with antibody
against MOG to label myelinated areas.
2.2.8 Neuraminidase (sialidase) treatment
Neuraminidase (Sigma) from Clostridium perfringens was dissolved in PBS pH 6.5 con-
taining 0.05% BSA (Finkelstein et al., 2007). 5 U/ml enzyme was added to cells for 1 hr
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at 37 °C before performing particles binding assay. The efficiency of sialic acid removal
by sialidase was assessed using WGA lectin staining.
2.2.9 Click-iT glycoprotein labeling and detection
Tetraacetylated azido-mannosamine (Ac4ManNAz) was used to measure the synthesis of
sialic acid. Cells were incubated with 50 µM Ac4ManNAz for 24 hr at 37 °C. The azido-
mannosamine was metabolically incorporated into glycoproteins and glycolipids through
the permissive feature of the oligosaccharide synthesis. The methabolically incorporation
of modified sugar into sialic acid biosynthesis was detected using fluorophore-conjugated
alkyne which specifically interacts with the azido-sugar. The amount of sialic acid incor-
poration into cells was analyzed using ImageJ software.
2.2.10 Exogenous gangliosides incorporation
Stock solution of total brain gangliosides was prepared in PBS containing 7 mM defatted
BSA. 12 µl of solution was loaded to 1 ml culture medium to obtain 80 µM concentration
of gangliosides and BSA. After incubating for 1 hr at 37 °C, cells were washed extensively
with PBS containing 2 mg/ml fatty acid free-BSA to remove excess lipids (Schwarzmann




Lipids from myelin membrane were extracted using chloroform-methanol approach (Bligh
and Dyer, 1959). 350 µl of myelin was added to 1050 µl chloroform-methanol (ratio 2:1).
The mixture was then vortexed vigorously and centrifuged at 6,000 rpm for 5 min at RT.
The organic phase (lower fraction) was recovered and added to 70 µl methanol and 475 µl
50 mM NaCl followed by mixing and centrifuging at 6,000 rpm for 5 min. The lower
organic phase containing lipids was collected and applied to speed vacuum for 45 min at
37 °C to obtain a dry lipid fraction.
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2.2.11.2 Liposome preparation and aggregation
Liposomes from myelin lipids with or without exogenous lipids were prepared as described
previously (Boggs et al., 1994; Ter Beest et al., 1994). Lipids (including proteolipid pro-
teins), extracted from myelin membrane, were dissolved in 2-chloroethanol to obtain the
total concentration of 1 mg/ml lipid/protein. The protein/lipid suspensions were briefly
centrifuged and dialyzed at RT for 6 hr against 2 litres of reconstitution buffer (5 mM
HEPES, 1 mM EDTA, and 10 mM NaCl, pH 5.0) using Slide-A-Lyzer MINI dialysis device
(Thermo scientific, Schwerte, Germany) with cut-off approximately 10 kDa. After three
times changing of dialysis buffer, the samples were collected and analyzed. To measure
liposome aggregation, the optical density of samples was monitored at 405 nm using a
Biophotometer Plus (Eppendorf) (Johnson and Chapman, 2010).
2.2.11.3 Dot blot
In order to immunolable the lipids in myelin liposomes, dot blot assay was performed. 8 µl
of liposomes was applied and dried into a nitrocellulose membrane. The membrane was
then incubated in blocking solution (5% skim milk powder in PBS) for 30 min at RT and
incubated with primary antibody in PBS at 4 °C overnight. After washing with PBS, the
membrane was incubated with the appropriate HRP-secondary antibodies for 40 min at
RT and the corresponded lipids were detected by enhanced chemiluminescence.
2.2.12 Immunocytochemistry and imaging
2.2.12.1 Immunocytochemistry
For immunoflourescence, cells were fixed with 4% paraformaldehyde (PFA) for 15 min at
RT and were permeabilized with 0.1% Triton X-100 in PBS for 1 min. Fixed cells were
then incubated with blocking solution (2% BSA, 0.2% Fish gelatine, and 2% FSC in PBS)
for 30 min at room temperature. Afterward, cells were incubated with primary antibodies
diluted in blocking solution for 1 hr, followed by three washing steps in PBS and then
incubated with secondary antibodies for another 1 hr. The glass coverslips were finally
mounted onto a glass slide with a drop of mowiol solution (2.4 g Mowiol, 6 g Glycerol,
6 mL H2O, 12 mL 0.2 M Tris-HCl pH 8.5) and dried overnight in the dark condition.
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2.2.12.2 Confocal Microscopy
The morphological analysis of fixed cell samples was performed using laser scanning con-
focal microscopy. Fluorescence images were acquired with Leica DMIRE2 microscope and
a Leica TCS SP2 AOBS confocal laser scanning setup (Leica Microsystems, Mannheim,
Germany).
2.2.12.3 Image Analysis
Quantification of the cell surface area of individual cells was approximated by measuring
the projected area (the area projected by a single cell onto a single optical plane) using
Meta Imaging software Series 6.1.
Quantification of myelin particles binding to cell surface area was assessed using ImageJ
and Leica Confocal software, 2.61.
Quantification of fluorescence intensities between different confocal images was performed
using ImageJ software. The mean intensity of fluorescent signal from different cell areas
was calculated and analyzed.
2.2.13 Atomic Force Microscopy (Single particle force spectroscopy)
Gold-coated cantilevers (Arrow TL2Au, Nanoworld) were used for single particle force
spectroscopy measurements. The cantilevers were washed twice in isopropanol and ultra-
pure water for 1 min each. Thereafter, cantilevers were cleaned using a plasma cleaner for
1 min. For binding of the myelin particles, the cantilevers were incubated in a 10 µg/mL
poly-D-lysine solution for 10 min and washed in ultra-pure water afterwards. Measure-
ments were performed using a CellHesion 200 setup (JPK Instruments, Berlin, Germany)
combined with an Olympus IX81 microscope (Hamburg, Germany) and a petridish heater
assuring a constant temperature of 37 °C throughout the measurement. A contact time
of 30 sec and a force of 500 pN were used to bind the particles to the poly-D-lysine
coated cantilever. For investigation of the myelin-oligodendrocytes interaction, the time
of particle-cell contact (5 sec), the force of approach (500 pN) and the velocity of can-
tilever retraction (5 µm/s) were kept constant throughout the measurements. To quantify
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the interaction between myelin particles and oligodendrocytes, maximum adhesion force
(minimum in force during cantilever retraction) from the recorded force retraction curves
was analyzed. To evaluate the statistics of the obtained data, a non-parametric statistical
hypothesis test, namely Wilcoxon rank-sum test, was employed.
2.2.14 Electron microscopy
2.2.14.1 Conventional embedding
Sample preparation for electron microscopy analysis was performed as described previously
(Mo¨bius et al., 2010). Briefly, the dissected nerves were chemically fixed by immersion
fixation in 4% PFA and 2.5% glutaraldehyde for 4 hr. The samples were then washed with
0.1 M phosphate buffer, postfixed with 2% OsO4 for 4 hr at 4 °C. They were afterward
dehydrated in a graded series of ethanol followed by propylene oxide and were infiltrated
with Epon-propylene oxide mixtures and pure Epon. The nerves were finally transferred
into embedding molds and polymerized for 24 hr at 60 °C.
2.2.14.2 High pressure freezing
The high pressure-freezing (HPF) of freshly extracted optic nerves was performed with
HPM100 (Leica, Vienna, Austria). The samples were placed in a 2 mm inner diameter
specimen carrier with 0.2 mm depth (Microscopy Services, Flintbek, Germany) surrounded
by 20% PVP (polyvinylpyrrolidone) in PBS to exclude the air inclusion around the sam-
ples and then frozen at 2000 bar for few milliseconds (Mo¨bius et al., 2010).
2.2.14.3 Freeze substitution and embedding
Freeze substitution was carried out for high-pressure frozen samples using a Leica AFS-
2 unit (Leica, Vienna, Austria). First the samples were placed in tannic acid (0.1% in
acetone) for 100 hr at -90 °C, then washed with acetone at -90 °C and subsequently incu-
bated with new substitution solution containing OsO4 (2% OsO4 in acetone, -90 °C) and
0.1% uranyl acetate. Afterward the temperature was increased from -90 °C to -20 °C in
increments of 5 °C/hr, and the samples were kept for 16 hr at -20 °C. The temperature
was raised further from -20 °C to +4 °C in increments of 10 °C/hr. The samples were
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next washed with acetone at 4 °C, allowed to adjust to room temperature for 1 hr and
were then transferred into Epon (50% Epon in acetone for 3 hr, 90% Epon in acetone
overnight, and 100% Epon for 6 hr). Finally, the samples were placed in embedding molds
and polymerized for 24 hr at 60 °C (Mo¨bius et al., 2010).
2.2.14.4 Sectioning and electron microscopy
The ultrathin sections for imaging were prepared using a Leica Ultracut S ultramicrotome
set and sections with 50 nm thick were cut. The sections were incubated in 2% aqueous
uranyl acetate for 30 min for contrasting, and then washed in water followed by lead
citrate for 5 min and again washed in water and dried. The imaging was performed using
an electron microscope LEO EM 912 AB (Zeiss, Oberkochen, Germany) used at 80 kV and
images recorded with a CCD camera 2048 x2048 (Proscan, Scheuring, Germany) (Mo¨bius
et al., 2010).
Negative staining electron microscopy was performed as described (Trajkovic et al., 2008).
Chapter 3
Results
3.1 The function of oligodendrocyte-derived exosome-like vesicles
in central nervous system
Most of the results in Section 3.1 have been published in:
Inhibition of myelin membrane sheath formation by oligodendrocyte-derived
exosome-like vesicles
Mostafa Bakhti, Christine Winter and Mikael Simons
J. Biol. Chem. 286(1):787-796 (2011)
3.1.1 Characterization of oligodendrocyte-derived exosomes
Exosomes from rat oligodendrocytes were collected using differential centrifugation from
the medium of cultured cells between 6 to 8 days after shaking. The amount of PLP was
evaluated in the different centrifugation steps to confirm the enrichment of this protein
in the exosomes fraction (P100) (Figure 3.1 A). Next, we explored the exosomes fraction
and cell lysate for different protein markers using western blot analysis. PLP, CNPase,
MAG and MOG were found as positive control proteins in exosomes, whereas there was
no signal for calnexin and Nogo A, considered as the negative markers to control the
presence of oligodendrocytes endoplasmic reticulum (ER) (Figure 3.1 B). The secretion
of exosomes by oligodendrocytes was also evaluated by electron microscopy. Negative
staining of oligodendrocytes-derived exosomes exhibited the presence of 30 to 100 nm
vesicles corresponding to exosome structures (Figure 3.2).
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Figure 3.1: Characterization of oligodendrocyte-derived exosomes. (A) A 6 to 8-day-old
medium from OLs was collected and submitted to different centrifugation steps as indicated. The
resulting pellets of each centrifugation step were analyzed by Western blotting for PLP. (B) Cell
lysate (CL) and exosomes (P100) were analyzed for different markers.
3.1.2 The effect of exosomes on myelination
To define the function of OL exosomes, their effect on the myelination process was exam-
ined in cell culture system. We used a primary oligodendrocyte-mixed brain co-culture
to assess the role of exosomes on myelination. Exogenous exosomes (0.1 µg/ml) were
added to one-day-old-co-culture and myelination was monitored after 4 days. MBP and
β-III-tubulin were used as the markers of oligodendrocytes and neurons, respectively. Sur-
prisingly, we found that exosomes significantly inhibited myelination in co-culture model
system (Figure 3.3 A). As shown in figure 3.3 B the number of MBP positive cells with
parallel structures are decreased in exosomes-treated sample as compared to the control.
These MBP positive cells with parallel structures have been previously described as myeli-
nating OLs (Stevens et al., 2002; Laursen et al., 2009).
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Figure 3.2: Electron microscopic of oligodendrocyte-derived exosomes. Electron micro-
scopic negative staining of P100 (100,000 × g) pellet showed the presence of 30 to 100 nm
vesicles. Scale bar, 50 nm.
Figure 3.3: Exosomes inhibit myelination. (A) OLs-neurons coculture was treated with exo-
somes for 4 days. The cells were immunolabled for β-III-tubulin (red) and MBP (green). Scale
bar, 100 µm. (B) ) The level of myelination was measured by counting the number of MBP cells
with multiple parallel processes (arrowhead) as a percentage of total MBP-positive cells (n = 3, *p
< 0.05; t-test). Scale bar, 50 µm.
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3.1.3 Effect of neuronal signals on exosome release by primary oligodendro-
cytes
After observing a regulatory role of exosomes in myelination process, we investigated
whether the secretion of exosomes was influenced by neuronal signals. It has been shown
that the treatment of oligodendroglial cells with conditioned medium from mixed brain
cultures (NCM) reduces the late endosomal/lyososomal pool of PLP (Trajkovic et al.,
2006). Therefore, a 14-day-old conditioned medium from mixed brain culture was used
as the source of neuronal signals. The medium of OLs on day 6 was substituted by fresh
medium or neuronal conditioned medium (NCM) and exosome release was monitored af-
ter 24 hr by measuring the amount of PLP in P100 fraction. Treatment of OLs by NCM
resulted in a significant decrease of exosome production by these cells (Figure 3.4 A).
More than 60 percent reduction in exosomal PLP level was detected during treatment of
OLs by NCM as compared to the control. Neuronal conditioned medium also reduced the
secretion of CNPase and Alix (Figure 3.4 B).
Figure 3.4: Neuronal conditioned medium reduces exosome release by OLs. (A) The
medium of OLs in day 6 was substituted by NCM and the exosomes preparation was performed
after 24 hr. (B) The amount of PLP, CNPase, and Alix from cell lysate and exosomes fraction was
quantified (n = 3, **p < 0.01; ***p < 0.001; t-test).
3.1.4 Effect of OL-derived exosomes on oligodendrocytes
We found that exosomes secreted by OLs inhibits myelination. Since the presence of
neurons reduced exosomes release by OLs, we proposed that exosomes may have some
3.1 The function of oligodendrocyte-derived exosome-like vesicles in the CNS 41
Figure 3.5: Exosome effects on the proliferation, viability, and differentiation of oligoden-
drocytes. (A) Cells were treated by 10 µM BrdU after one day of seeding. The proliferation
assay was performed after 24 hr (n = 3). (B) B-27 supplement depletion was used to induce OLs
cell death. Treatment with exosomes did not prevent oligodendrocytes mortality (n = 50 confocal
images from two different experiments). (C) Treatment of OLs by NCM for 3 days induced their dif-
ferentiation, which was measured by increase in the percentage of MBP positive cells. Exosomes
did not change this process (n = 3, ***p < 0.001; one-way ANOVA).
autocrine effects on oligodendrocytes. Therefore, we assessed the effect of exosomes on
different stages of oligodendrocyte development. First, we examined whether exosomes
modulate oligodendrocyte proliferation by performing a bromodeoxyuridine (BrdU) assay
on freshly plated cells. No significant alteration in BrdU incorporation was observed in
exosome-treated oligodendrocytes when compared to the controls (Figure 3.5 A). We next
investigated the possible effects of exosome-like vesicles on oligodendrocyte survival by ap-
plying a growth factor depletion assay (Laursen et al., 2009). Removal of B-27 supplement
induced cell death, which was not affected by the treatment with exosomes (Figure 3.5 B).
We also explored the effect of exosomes on oligodendrocyte differentiation. When oligo-
dendrocytes were cultured in normal medium or in NCM and analyzed 2-3 days later, we
observed that NCM promoted oligodendrocyte differentiation as detected by an increase
in the fraction of MBP-positive cells. Treatment of oligodendrocytes with exosome-like
vesicles, however, did not affect this process (Figure 3.5 C). Differentiated oligodendro-
cytes undergo the final step of their development to produce a large amount of myelin
membrane. This stage correlates with expansion of the cell surface area and production
of large membrane sheets required for myelin biogenesis. Many different factors have been
reported to affect the OL surface branching which subsequently influence their myelinating
properties (Rajasekharan et al., 2009; Laursen et al., 2009; Baer et al., 2009). We next
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studied whether the inhibitory effect of exosomes on myelination is by influencing the OL
branching. NCM treatment resulted in a relatively robust increase in the size of oligo-
dendrocytes in comparison to the cells kept in unconditioned control medium. This effect
was observed in both undifferentiated (A2B5-positive) and differentiated (MBP-positive)
cells (Figure 3.6 A). Interestingly, incubation of cells with exosome-like vesicles reversed
the effect of NCM on cell surface expansion (Figure 3.6 B).
Figure 3.6: Exosomes inhibit cell surface expansion of oligodendrocytes. (A) The effect
of NCM and exosomes on OLs morphology is represented. Oligodendrocytes were treated for
3 days with NCM and incubated with exosomes during the last 2 days. Scale bar, 50 µm. (B)
Cell surface area of A2B5- and MBP-positive cells was quantified. NCM treatment enhanced OL
cell surface area compared to the controls, which were cultured in the fresh medium. Addition
of exosomes prevented the effect of NCM and induced OLs surface retraction (n = 50 confocal
images from three different experiments, ***p < 0.001; one-way ANOVA).
3.1.5 RhoA pathway involvement in exosome effect on OLs
Having identified a role of exosome-like vesicles in regulating cell surface size, we inves-
tigated the potential signal transduction pathways involved in this process. The mTOR
signalling is known to regulate the myelin membrane formation in oligodendrocytes (Tyler
et al., 2009; Narayanan et al., 2009). Activation of mTOR signalling results in the phos-
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Figure 3.7: Exosomes do not influnce
the mTOR pathway. OLs were cultured for
3 days and subsequently treated with NCM
and exosomes as indicated. Cells were an-
alyzed by western blotting using specific an-
tibodies against phosphorylated Akt (Ser-
473), Akt, phosphorylated ribosomal sub-
unit 6 (Ser-236), and actin as the loading
control.
phorylation of Akt and the ribosomal subunit 6 (rS6). However, exosome-like vesicles did
not change the phosphorylation status of these proteins when compared to control condi-
tions, which argues against the involvement of this pathway in mediating the changes in
cell surface area (Figure 3.7).
Inactivation of RhoA pathway has been described to play a central role in the oligoden-
drocyte process branching (Liang et al., 2004; Kippert et al., 2007, 2009). Therefore,
we explored the involvement of this pathway in exosome induced OLs retraction. In-
deed, when we applied the Rho-associated kinase (ROCK) inhibitor Y-27632 (Y27), the
inhibitory effect of exosome-like vesicles on cell surface expansion was prohibited (Fig-
ure 3.8 A). Similar results were obtained when the myosin-II inhibitor, blebbistatin, was
introduced in the experiments (Figure 3.9 A). Intriguingly, we found that both blebbis-
tatin and Y27 did not affect cell surface size of oligodendrocytes cultured in NCM in the
absence of exosome-like vesicles (Figure 3.8 B, Figure 3.9 B). Taken together, these data
indicate that exosome-like vesicles activate the Rho-ROCK-Myosin signalling axis to in-
hibit cell surface expansion of oligodendrocytes.
To verify the involvement of RhoA pathway, its activity was measured by affinity pre-
cipitation of active (GTP-bound) Rho from cell lysates using agarose beads containing
the Rho-binding domain of Rhotekin. Pull-down approach revealed that the active form
of RhoA (RhoA-GTP) is increased upon treatment of oligodendrocytes with exosome-
like vesicles (Figure 3.10 A). To obtain further support for this pathway, we assessed the
phosphorylation level of myosin light chain 2 (MLC2), a downstream molecule of RhoA-
ROCK. We found that MLC2 phosphorylation level is elevated when cells were treated
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Figure 3.8: Inhibition of ROCK prevents the effect of exosome on cell surface size. (A)
Oligodendrocyte cells were treated with NCM and exosomes in the absence or presence of 10
µM Y27632 (Y27) as the ROCK inhibitor. Scale bar, 50 µm. (B) Y27 did not affect the surface area
of cells treated with NCM, but reduced the inhibitory effect of exosomes on cell surface expansion.
Black column, without Y27; blue column, with Y27. (n = 42 confocal images from three different
experiments, ***p < 0.001; t-test)
with exosome-like vesicles (Figure 3.10 B). These data demonstrate that exosome-like vesi-
cles act by influencing actomyosin contractility in oligodendrocytes.
3.1.6 Fyn and FAK phosphorylation are involved in exosomes effect on OLs
Fyn is a member of Src family kinases (SFKs), and plays a vital role in myelination of the
CNS (Liang et al., 2004). This protein has been shown to affect the differentiation and
myelination steps of OLs. Activation of Fyn suppresses RhoA pathway and increases OLs
process branching (Goto et al., 2008; Caˆmara et al., 2009; Laursen et al., 2009; Relucio
et al., 2009). To indicate whether NCM increases oligodendrocyte surface area in a Src
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Figure 3.9: Inhibition of myosin-II reduces the effect of exosome on cell surface size. (A)
Oligodendrocytes were treated with NCM and exosomes in the absence or presence of 50 µM
blebbistatin (Blebb) as the myosin-II inhibitor. Scale bar, 50 µm. (B) Blebb did not influence the
surface area of cells treated with NCM, but decreased the inhibitory effect of exosomes on cell
surface expansion. Black column, without Blebb; blue column, with Blebb. (n = 30 confocal
images from two different experiments, ***p < 0.001; t-test)
kinase-dependent signalling, we used the small molecular inhibitor, PP2. Treatment of
cultured oligodendrocytes with PP2 inhibited the cell surface expansion induced by NCM,
confirming involvement of Src proteins (Figure 3.11 A, B). Fyn activity is regulated by two
different phosphorylation sites. Phosphorylation of tyrosine 420 and 531 residues lead to
activation and inactivation of this protein, respectively. We examined the phosphorylation
status of Tyr-420 and Tyr-531 after exosome treatment. Western blot analysis revealed
a significant decrease in the activating (Tyr-420), but not the inactivating phosphoryla-
tion site (Tyr-531) in cells which had been incubated with exosomes (Figure 3.12 A, B).
Fyn signalling is connected to another kinase, the focal adhesion kinase (FAK), which
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Figure 3.10: Inhibition of actomyosin contractility prevents the effect of exosomes on
oligodendrocytes cell surface area. (A) Using a pull down assay, the amount of active RhoA
(RhoA-GTP) was measured during treatment of oligodendrocytes with NCM and exosomes. (B)
Treated cells were also analyzed for changes in phosphorylation level of myosin light chain 2
(MLC2) protein (n = 3, *p < 0.05; t-test).
has been reported to modulate CNS myelination (Umemori et al., 1994; Forrest et al.,
2009). Integrins and numerous extracellular signals activate FAK, which in turn leads to
FAK autophosphorylation at Tyr-397, generating a binding site for the Src homology 2
(SH2) domain of SFKs such as Fyn. We tested the autophosphorylation level of tyrosine
397 residue in FAK and observed a significant decrease in Tyr-397 phosphorylation after
exosome treatment (Figure 3.13 A, B).
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Figure 3.11: NCM increases cell surface area by activation of Src proteins. (A) NCM-treated
oligodendrocytes were cultured for 3 days in presence or absence of Src family kinase inhibitor
(PP2), for the last 2 days. Scale bar, 100 µm. (B) While PP2 reduces the surface area of NCM-
treated cells, it did not affect cells, cultured in control medium. Black column, without PP2; blue
column, with PP2 (n = 40 confocal images from three different experiments, ***p < 0.001; t-test).
Figure 3.12: Exosomes affect phosphorylation of Fyn protein. (A) Western blot analysis for
OLs treated with NCM or exosomes using SFK (pY418), SFK (pY529) and Fyn specific antibodies.
(B) The quantification of 4 independent experiments is presented. (*p < 0.05; t-test).
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Figure 3.13: Exosomes inhibit autophosphorylation of Focal adhesion kinase (FAK). (A)
The autophosphorylation of FAK was evaluated using antibody against phosphorylated tyrosine
397. (B) Phosphorylation level of FAK during OLs treatment with NCM and exosomes from 3
independent experiments is shown. (**p < 0.01; t test).
3.2 Mechanism of myelin membrane adhesion and compaction in
central nervous system
Most of the results in Section 3.2 have been prepared for publication:
PLP adhesive property and sialic acid removal increase myelin adhesion and
stability in the CNS
Mostafa Bakhti, Nicolas Snaidero, David Schneider, Shweta Aggarwal, Wiebke
Mo¨bius, Andreas Janshoff, Matthias Eckhardt, Klaus Armin Nave and Mikael
Simons
Manuscript under preparation
3.2.1 A new assay to assess myelin membrane adhesion in vitro
Most of our knowledge about myelin structure is based on an approaches employing elec-
tron microscopy and mouse genetic. Due to its tightly packed structure, cell biological
mechanisms regulating myelin assembly can not be studied easily by light microscopy. Be-
cause of limitations with current approaches, the exact mechanism of myelin compaction
remains obscure. It is known that primary oligodendrocytes produce myelin-like mem-
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Figure 3.14: Binding assay. The schematic and confocal images of the interaction between
labeled myelin particles and primary oligodendrocytes (OL) are presented. Scale bar, 20 µm.
brane sheets in culture, which resemble compacted myelin membrane in vivo (Aggarwal
et al., 2011b). Using this model system, our aim was to establish a new assay where the in-
teraction between two myelin bilayers can be reconstituted. Therefore, we investigated the
interaction between prepared myelin particles and primary oligodendrocytes (Figure 3.14).
3.2.2 The preparation and characterization of myelin particles
Myelin membrane, purified from adult mice brain, was sonicated to obtain myelin par-
ticles. To establish the binding assay those particles were required that resemble the
compacted area of myelin (enriched in PLP) and have low content of glycoproteins, which
localize to noncompact region. For this purpose, we used Concanavalin A beads to remove
glycoprotein fraction from prepared particles. The obtained fractions were then treated
with calcium to eliminate MBP, which exerts strong adhesion forces on negative surfaces.
The purified particles were then analyzed using western blotting. A visible reduction in
MAG and CNPase level was observed, during preparation. Furthermore, the amount of
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Figure 3.15: Preparation and characteri-
zation of myelin particles. Purified myelin
membrane was sonicated and subjected to
ConA glycoprotein isolation beads. The flow
through (FT) was then incubated with cal-
cium for 3 hr at 37 °C. Western blot analysis
was performed for different fractions for the
indicated proteins.
MBP was also decreased whereas PLP level was unchanged (Figure 3.15).
Myelin particle preparation was also explored using immunostaining. We used antibodies
which react against PLP and CNPase and stained the particles with the lipophilic dye
PKH26 as the reference. After preparation most particles stained for PLP whereas the
staining for CNPase was reduced, confirming the enrichment of compact myelin protein
in these particles (Figure 3.16).
3.2.3 Myelin particles preferentially bind to oligodendrocyte membrane surface
We evaluated the binding of prepared myelin particles to different glial cells in the CNS.
We found that these particles bind preferentially to mature oligodendrocytes in compar-
ison to astrocytes and A2B5-positive cells, immature oligodendrocytes. Meanwhile the
particles were internalized by the phagocytic microglial cells and subsequently accumu-
lated in their cytoplasmic compartments (Figure 3.17).
Z-stack confocal imaging revealed that the myelin particles were localized on the surface
of oligodendrocytes, thus excluding possible engulfment by these cells (Figure 3.18).
3.2 Mechanism of myelin membrane adhesion and compaction in CNS 51
Figure 3.16: Immunolabeling of myelin particles. Control myelin and purified particles were
immunolabeled with antibodies against PLP and CNPase and co-stained with the lipophilic dye
PKH26 for the reference. Scale bar, 20 µm.
3.2.4 PLP plays a role in the interaction of myelin particles with OLs
PLP and MBP are the main components of CNS myelin proteins (Jahn et al., 2009).
While MBP has been shown to form a molecular sieve and mediate close apposition of
myelin bilyers on the cytsolic side (Aggarwal et al., 2011b), the mechansims which regulate
adhesion of myelin membranes on the extracelullar leaflet remain obscure. We explored
the role of PLP in mediating myelin membrane adhesion and compaction. For this, we
used myelin particles and oligodendrocytes from PLP knockout (KPLP) mice (Klugmann
et al., 1997). We incubated either wild type or KPLP myelin particles with wild-type
(WT) OLs and measured the number of bound particles per unit cell area. The number of
particles bound per cell was significantly higher in WT cells compared to the KPLP cells
(Figure 3.19 A, B). We also added WT particles to a mixed culture of WT and KPLP OLs.
We again, detected more binding of the particles to WT than KPLP cells (Figure 3.19 C).
These data show possible role of PLP in mediating interaction of myelin particles with
oligodendrocytes.
Next, we investigated the interaction between myelin particles and OLs when PLP was
present only in one of the membranes. Incubation of KPLP cells with either WT or KPLP
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particles revealed a significantly higher interaction for the WT particles (Figure 3.20 A, B).
Afterwards, we added KPLP myelin particles to the mixed cultures of WT and KPLP cells.
Again, the interaction was higher between WT cells and KPLP particles (Figure 3.20 C).
These data show that presence of PLP on one side increases the interaction between myelin
particles and oligodendrocytes, suggesting the possible interaction of PLP with other un-
known molecules. However, PLP might also interact with another PLP molecule on the
opposite membrane.
To obtain further evidence for the adhesive role of PLP, we performed an in vitro myelin-
myelin interaction assay. First, we stained purified myelin particles with two different dyes,
PKH26 (red) and PKH67 (green). Second, we incubated these two different population
of particles on a rotating device for 1 hr. After incubation, we added the particles onto
coverslips followed by fixation. Next, we analyzed the percentage of particles which interact
amongst total population. Using this system we studied the interaction between WT-WT
and KPLP-KPLP myelin particles. In comparison to KPLP myelin, higher interaction
was observed between WT particles (Figure 3.21) supporting the adhesive role of PLP.
Reconstitution of transmembrane proteins in artificial vesicles is a useful tool to study
their function (Ter Beest et al., 1994; Bizzozero and Howard, 2002). To obtain direct
evidence of PLP function in myelin membrane adhesion, we prepared liposomes contain-
ing PLP. Because of its hydrophobicity, PLP can be recovered within the lipid fraction
during myelin lipid extraction. Taking advantage of this property, liposomes were pre-
pared from myelin extracted lipids and their aggregation was monitored (Figure 3.22 A).
We observed more aggregation between WT myelin-derived vesicles in comparison to ones
derived from KPLP myelin lipids (Figure 3.22 B). These absorbance assays were compli-
mented by negative staining electron microscopy which also revealed greater accumulation
for WT vesicles (Figure 3.22 C). Altogether, these findings suggest an adhesive role for
PLP in myelin bilyer interaction on the extracellular sides.
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Figure 3.17: Interaction of myelin particles with different glial cells. Purified labeled particles
were added to different glial cell preparations including; astrocytes, microglia, undifferentiated
and differentiated oligodendrocytes. MBP-positive cells showed high affinity for myelin particles
whereas A2B5-positive cells had no interaction with these particles. Moreover, astrocytes re-
vealed low binding for the particles which were in contrast endocytosed by microglia (arrowheads).
Scale bar, 20 µm.
3.2.5 PLP increases physical stability of myelin
If PLP plays a role in myelin compaction it is likely that this protein influences myelin
stability (Klugmann et al., 1997). To test this possibility, we investigated the physical
stability of myelin in the absence of PLP. We examined the morphological differences be-
tween myelin derived from WT and PLP knockout mice. Therefore, the size distribution
of prepared myelin particles from two different samples were analyzed. When compared
to KPLP myelin, WT particles showed a distribution tendency towards larger size (Fig-
ure 3.23), indicating a stronger physical stability of particles in the presence of PLP during
myelin preparation. Whether the cis interaction between PLP molecules in the same lipid
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Figure 3.18: Myelin particles interact with the myelin-like membrane surface. Myelin parti-
cles were added to 5-day-old oligodendrocytes and analyzed for the position of bound particles
using confocal microscopy. ImageJ analysis revealed the localization of myelin particles with the
surface of oligodendrocyte myelin-like membrane. Scale bar, 20 µm.
bilayer or their trans association from the two opposite membranes increases myelin sta-
bility, cannot be concluded from this observation.
To support the role of PLP in myelin membrane stability, the interaction of myelin particles
with oligodendrocytes was investigated using single-particle force spectroscopy. The ob-
tained force-distance curves (Figure 3.24 A) revealed mean maximum adhesion strengths
of 248 ± 93 pN for WT myelin particles with WT oligodendrocytes and 210 ± 87 pN
for KPLP particles interacting with PLP knockout cells. According to the performed
Wilcoxon rank-sum test, the distributions showed significant differences (p < 0.05, Fig-
ure 3.24 B). Interestingly, force distance curves of measurements with KPLP particles
showed significantly higher perturbations than those for measurements with WT particles
(Figure 3.24 A). We attributed these increased fluctuations during approach and retrac-
tion to the instability of KPLP particles leading to thermally excited oscillations of the
cantilever due to undulations of the liquid particles. This assumption is also supported by
the fact that in case of WT particles 80% of the recorded force curves could be analyzed,
whereas for KPLP particles only 60% of the curves could be used due to perturbations
occurring during the contact regime. Power spectral density obtained by Fast Fourier anal-
ysis of the approach curves revealed the frequency-dependent motion of KPLP particles
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Figure 3.19: PLP increases particle-cell interaction. (A) WT and KPLP myelin particles were
added to WT cells and the number of particles per cell area was calculated. WT particles showed
more affinity towards OLs compared to KPLP myelin. (B) The reference images for two different
particles are represented. (C) WT myelin particles were added to a mixed culture of WT and
KPLP cells and the number of particles per cell area was calculated. An increase in binding for
WT oligodendrocytes was observed compared to the KPLP cells. (n = 3, **p < 0.01; t-test). Scale
bar, 20 µm.
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Figure 3.20: Presence of PLP in one side of interacting membranes, increases the binding
of particles to oligodendrocytes. (A) WT and KPLP myelin particles were added to KPLP cells
and the number of particles per cell area was calculated. WT particles showed more affinity
toward OLs compared to KPLP myelin. (B) The reference images for two different particles are
represented. (C) KPLP myelin particles were added to a mixed culture of WT and KPLP cells and
the amount of particles binding was measured. An increase in binding for WT oligodendrocytes
was observed compared to the KPLP cells. (n = 3, **p < 0.01;***p < 0.001; t-test). Scale bar,
20 µm.
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Figure 3.21: PLP increases the interaction between myelin membrane particles. Myelin
particles were labeled with two different dyes; PKH26 (red), and PKH67 (green). After incubation
for 1 hour at room temperature the mixture of particles was applied on coverslips for 3 hr and
then was fixed. The percentage of bound particles (arrowheads) was measured using confocal
imaging. Higher interaction between WT particles was observed compared to the KPLP myelin.
(n = 3, ***p < 0.001; t-test). Scale bar, 20 µm.
in comparison to wild-type ones (Figure 3.24 C). Whereas WT particles were stable and
thus perturbed cantilever movement in a negligible fashion, the unstable KPLP particles
resulted in oscillations during the experiment. This oscillations are reflected in significant
peaks within the recorded frequency spectrum. The occurrence of a high number of peaks
in the spectrum for KPLP particles stressed the increased flexibility of this type of particle.
These data demonstrate that PLP not only plays an essential role in the stabilization of
the myelin particles, but is also important for the interaction between myelin and myelin-
like membrane.
To investigate the stability of myelin membrane in the absence of PLP in vivo we per-
formed electron microscopic analysis. Electron micrographs of optic nerve prepared by
high pressure freezing (HPF) approach did not show any abnormality in area with optimal
preservation (Figure 3.25 A) which was consistent with previous observations (Klugmann
et al., 1997; Mo¨bius et al., 2008). However, area with sub-optimal preservation displayed
more lamella splitting for the mutant myelin (Figure 3.25 A). This has been explained by
fixation artifact occurring during sample preparation (Mo¨bius et al., 2008). Therefore, to
obtain reproducible information, we applied conventional embedding fixation. Analysis of
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Figure 3.22: PLP increases aggregation of myelin-derived liposomes. (A) Liposomes were
prepared by dialysis approach using lipids from WT and KPLP myelin. Western and dot blot
analysis were performed to assess PLP and GalC in liposomes, respectively. (B) Liposome ag-
gregation was carried out by measuring the optical density of samples at 405 nm. Liposomes
from WT revealed more aggregation in contrast to those from KPLP myelin (n = 6, ***p < 0.001; t-
test). (C) Typical images of negatively stained WT and KPLP liposomes as visualized by electron
microscopy. Scale bar, 2 µm.
optic nerve from P14 animals revealed a higher periodicity in case of mutant myelin when
compared to the WT mice (Figure 3.25 B). Taken together, these data provide evidence
for the role of PLP in maintaining the stability of myelin membrane in vivo.
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Figure 3.23: PLP increases the size of myelin particles. Purified myelin without sonication
was incubated with ConA glycoprotein isolation beads. The passed flow through fractions were
stained with PKH26 dye and fixed on coverslips. Using confocal imaging the size distribution of the
particles was analyzed. Myelin particles derived from WT mice showed a larger size distribution
compared to the KPLP. Scale bar, 20 µm.
In general, adhesive properties of biological membranes rely on different factors: genetic
expression of receptors at the cell surface and generic forces (non-specific forces) which
require removal of repulsive structures mainly glycocalyx components from membrane
(Sackmann and Bruinsma, 2002). Having shown PLP protein as an adhesive molecule
in the CNS myelin, we continued to determine the possible effect of glycocalyx removal,
which might be necessary for generating generic forces during myelin compaction.
3.2.6 Reduction in glycocalyx during oligodendrocytes maturation correlates with
an increased in membrane adhesiveness
Lectins are proteins which are extensively used to study glyco-structures in biological sys-
tems (Kitada et al., 2011; Niehaus and Trotter, 1997). To analyze the alteration in OLs
glycocalyx during their maturation, we used lectin staining approach. We applied different
lectins which recognize specific sugar epitops. For this, we exploited the binding of Con A,
PNA (Peanut Agglutinin), and WGA (Wheat Germ Agglutinin) lectins to oligodendroglial
cells at day 2 and 5 of their differentiation. Whereas all of these lectins stained OLs at day
2, they only weakly bound to cells at day 5 (Figure 3.26). In addition, we examined RCA
120, SBA, UEA I, and SNA lectins which did not show any binding to differentiated OLs
(data not shown). These data indicate that most types of sugar complexes are reduced in
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Figure 3.24: Single particle force spectroscopy shows stronger adhesion between par-
ticles and cells in the presence of PLP. (A) Exemplary force distance curves of WT myelin
particles interacting with WT oligodendrocytes, and KPLP myelin particles interacting with KPLP
cells. From these force curves the maximum adhesion force was analyzed; Approach curve (red),
Retraction curve (blue). (B) Box-plots for the maximum adhesion force of KPLP myelin particles
interacting with KPLP oligodendrocytes (green) and WT myelin particles interacting with WT cells
(red), are represented. According to the Wilcoxon rank-sum test, both distributions are signifi-
cantly different at the 0.05 level (p=0.006). (C) Power spectral density obtained from Fast Fourier
analysis of the corresponding base-line corrected approach curves; approach curves of KPLP par-
ticle (green) and of WT particle (red) bound to the poly-D-lysin coated cantilever, were recorded
with a data rate of 2049 Hz. For analysis only data points before reaching the contact point were
used.
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Figure 3.25: The stability of myelin is reduced in the absence of PLP. (A) Optic nerves from
P21 mice were prepared by high pressure freezing (HPF) approach. Electron micrographs of the
samples revealed normal myelin structure for KPLP in areas with optimal preservation. However,
KPLP samples in areas with sub-optimal preservation displayed increased lamella splitting com-
pared to WT. (B) Optic nerves from P14 mice were prepared by conventional embedding fixation.
Electron micrographs of the samples were obtained and the average distance between myelin
lamella was measured. (n = 15 images from 3 animals, ***p < 0.001; t-test). Scale bar, 1 µm.
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the surface of OLs during their maturation.
Based on lectin staining, we hypothesized that the alteration in glycocalyx may change
OLs membrane adhesion during their maturation. To investigate this possibility, we per-
formed a binding assay, in which myelin particles were added to OLs at day 3 and 5 of
their differentiation, and the number of particles per cell area was calculated. An obvious
increase in particles binding was detected for the cells at day 5 compared to those at day
3 (Figure 3.27 A). Since PLP was shown to mediate the particle-OL interaction and the
level of this protein is increased during OLs maturation, we performed the same exper-
iment using PLP knockout cells. An increase in particles binding during maturation of
KPLP cells was also observed (Figure 3.27 B). Taken together these data indicate that
another factor beside PLP protein is involved in increasing myelin adhesiveness during
OLs maturation which might be relevant to the reduction in their surface glycocalyx.
Figure 3.26: A massive reduction in the surface glycocalyx occurs during oligodendro-
cytes maturation. Cultured oligodendrocytes at day 2 and 5 were assessed for their surface
glycocalyx using different lectins. ConA, PNA, and WGA staining showed a clear reduction in the
cell surface sugars upon maturation of the cells. Scale bar, 20 µm.
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Figure 3.27: Myelin-like membrane adhesiveness is increased during oligodendrocytes
maturation. (A) Myelin particles were added to cells at different days in development and the
number of particles per cell area was measured. Particle binding was higher in immature (day 3)
compared to mature (day 5) cells. (n = 3, **p < 0.01; t-test) (B) Myelin particles were incubated
with KPLP cells in different time points of their differentiation. An increase in particle binding was
detected for cells during later steps of maturation (n = 4, ***p < 0.001; t-test). Scale bar, 20 µm.
64 3 | Results
3.2.7 Reduction of sialic acid from myelin-like membrane increases OLs affinity
towards myelin particles
Due to its negative charge, sialic acid is an important repulsive molecule which influences
cell-cell interaction. For instance, addition of polysialic acids to NCAM reduces the adhe-
sion between two biological membranes (Rutishauser et al., 1990). We, therefore, focused
on the role of this molecule during myelin membrane adhesion and compaction. Although
WGA binds to sialic acid containing moieties, it also binds to other sugar molecules. To
detect sialic acid more specifically, we used MAL II lectin, which interacts only with the
epitopes containing sialic acid. OLs at day 2 and 5 as well as microglial and astrocytic cells
were stained for MAL II. Whereas day 2 oligodendrocytes, microglia, and astrocytes were
robustly stained with MAL II, OLs at day 5 showed only weak staining (Figure 3.28 A),
pointing towards a process in which sialic acid levels go down during myelin membrane
maturation.
To obtain further evidence for the reduced levels of sialic acid during myelin membrane
maturation, we measured incorporation of this sugar, using metabolic labeling approach.
In this method, cells are incubated with an azide-modified molecule which is metabolically
incorporated into cells. Using chemoselective ligation or click reaction between the azide
and a fluorescent-attached alkyne, the labeled metabolic molecule can be identified in the
cells. We used tetraacetylated N-Azidoacetyl-D-Mannosamine (Ac4ManNAz) molecule
which is metabolically incorporated into sialic acid biosynthetic pathway. We performed a
time course experiment, in which cells at day 0, 2, and 4 were incubated with Ac4ManNAz
and the amount of integrated sialic acid was detected after 24 hr. We found a significant
reduction in sialic acid biosynthesis during oligodendrocytes maturation (Figure 3.28 B).
However, time course experiment with astrocytes did not show any differences in sialic
acid metabolism (Figure 3.28 C).
After observing the reduction of sialic acid during oligodendrocyte development in vitro,
we investigated whether the level of this sugar in myelinated area is different from other
brain regions. Brain slices from adult mice were stained with fluorophore conjugated WGA
and MAL II. The staining was far less pronounced in myelin enriched areas, such as corpus
callosum, in comparison to other regions of the braine (Figure 3.29). These data suggest
that the glycocalyx components are indeed present in low proportion in the myelinated
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Figure 3.28: Sialic acid content is reduced during oligodendrocytes maturation. (A) Oligo-
dendrocytes at day 2 and 5 after plating as well as microglia and astrocytes, were labeled using
MAL II lectin which specifically binds to sialic acid. Confocal images obtained with the same gain
demonstrated a reduction in surface sialic acid for oligodendrocytes at day 5 compared to the cells
at day 2 and other types of glia. (B) Oligodendrocytes at different stages of their differentiation
were treated with 50 µM Ac4ManNAz for 24 hr. The cells were then labeled using a fluorescent
alkyne to detect the incorporated sialic acid. A significant reduction in sialic acid biosynthesis
was observed during oligodendrocyte maturation. (n = 4, ***p < 0.001; one-way ANOVA). (C)
Astrocytic cells in the similar days were also treated with Ac4ManNAz. However no significant
changes were found in sialic acid biosynthesis for these cells. (n = 4, n.s = not significant; one-
way ANOVA). Scale bar, 20 µm.
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Figure 3.29: Myelinated area possess low sialic acid content. Lectin stainings of brain sec-
tions from two-month-old wild-type mice is represented. WGA and MAL II staining showed a
striking reduction in lectin binding in area corresponding to myelinated regions, which are shown
by staining with antibody directed against MOG. Scale bar, 200 µm.
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area in vivo.
Having found a reduction in sialic acid level during myelination, we continued to analyze
whether removing sialic acid residues from myelin-like membranes can potentially increase
their adhesiveness. For this purpose, we used 3-day-old OLs which still have a consider-
able amount of glycocalyx on their surface. When treated with neuraminidase (sialidase),
derived from Clostridium perfringens, cells revealed more interaction with myelin par-
ticles (Figure 3.30 A, B). Altogether, we show that during oligodendrocyte maturation,
the levels of sialic acid are notably reduced, which in turn correlates with the increased
adhesiveness of myelin membrane.
3.2.8 Negative surface charges interfere with myelin membrane adhesiveness
Because sialic acid residues contribute to the negative charge of the plasma membrane,
we asked whether these charges interfere with the interaction of two opposing membranes.
For this, we added a negatively charged molecule, dextran sulfate, to the cells. This
substance has been reported to bind to the cell surface (Strilic´ et al., 2010). Treatment
of cells with dextran sulfate significantly reduced the interaction of myelin particles with
oligodendrocytes in comparison to the uncharged dextran, which was used as the negative
control (Figure 3.31 A). We next asked whether neutralization of negative charges could
increase myelin-like membrane adhesiveness. To this end, we used cationic protamine
sulfate, which has been shown to neutralize the negative charges of sialic acids (Strilic´ et al.,
2010). When added to 3-day-old cells, which still possess glycocalyx as well as negative
charges on their surface, protamine sulfate increased the binding of myelin particles to
OL surface (Figure 3.31 B). These experiments show that cell surface negative charges
interfere with the binding of myelin particles to oligodendrocytes.
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Figure 3.30: Enzymatic removal of sialic acid enhances the interaction between oligoden-
drocyte surface with myelin particles. (A) Oligodendrocytes at their early stage of differen-
tiation (day 3) were treated with 5 U/ml sialidase for 1 hr at 37 °C and the binding assay was
performed. Treatment of cells with the enzyme resulted in increased interaction between myelin-
like membrane and the particles compared to the control cells. (n = 4, ***p < 0.001; t-test). (B)
The reduction of sialic acid from cell surface after enzymatic treatment was confirmed using WGA
lectin staining. Scale bar, 20 µm.
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Figure 3.31: Cell surface negative charges reduce myelin particle interaction with oligo-
dendrocytes. (A) Fully differentiated oligodendrocytes were treated with 5 mg/ml dextran and
dextran sulfate for 30 min at 37 °C. The binding assay was performed and the number of parti-
cles per cell area was assessed. The particles binding for cells treated with dextran sulfate was
considerably less than those treated with dextran (n = 4, ***p < 0.001; t-test). (B) Cells in early
differentiation step were incubated with 50 µg/ml protamine sulfate for 15 min at 37 °C. Introducing
of myelin particles resulted in more interaction with protamine sulfate-treated cells than controls.
(n = 5, ***p < 0.001; t-test). Scale bar, 20 µm.
3.2.9 Partially glycocalyx reconstitution reduces particle-cell interaction
MBP has been reported to form a size barrier which restricts proteins with large cytoplas-
mic domain to the non-compact areas. By this filtering mechanism, myelin sheets become
devoid of most glycoproteins (Aggarwal et al., 2011b). To reconstitute glycoproteins in
myelin-like membrane we used OLs from MBP knockout mice (Shiverer). When compared
to the WT, shiverer cells showed a significant reduction in myelin particle binding, indi-
cating the interfering of glycoproteins with myelin membranes interaction (Figure 3.32 A).
To support the inhibitory role of glycoproteins in myelin membrane adhesion, we applied
different constructs of S-MAG, which contains many N-linked glycosylation sites. We used
a cytoplasmic truncated version of S-MAG (S-MAG N ter) that has been shown to enter
the compact area. As a negative control, we used the full length protein (S-MAG), which
is restricted to the non-compact region (Aggarwal et al., 2011b). A significant reduction
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in particles binding was observed for cells transfected with truncated MAG in comparison
to the control cells that were trasnfected with the full length protein (Figure 3.32 B),
pointing to the repulsive effect of this glycoprotein on particle-cell interaction.
Figure 3.32: Partially reconstitution of glycocalyx into myelin-like membrane decreases
its interaction with myelin particles. (A) A mixed culture of WT and Shiverer primary oligo-
dendrocytes was prepared. WT myelin particles were added to the culture and the number of
particles per cell area was counted. A considerable decrease in myelin particles binding was de-
tected for Shiverer cells compared to WT. (n = 5, **p < 0.01; t-test). (B) Oligodendrocytes were
transfected with full length (S-MAG-myc), and cytoplasmic truncated (S-MAG N ter-myc) MAG.
The cells expressing cytoplasmic-truncated MAG revealed less interaction with myelin particles
in comparison to oligodendrocytes transfected with full length protein. (n = 4, **p < 0.01; t-test).
Scale bar, 20 µm.
To obtain additional evidence regarding inhibitory role of glyco-structures in myelin mem-
branes interaction, we reconstituted gangliosides, which contain a considerable amount
of sialic acid, into OLs membrane. The levels of these lipids have been reported to be
reduced during myelin maturation (Cochran et al., 1982). When total brain gangliosides
were loaded into OLs, a notable decrease in particles binding was revealed in contrast to the
control (Figure 3.33 A). Consistent with this observation, introducing of gangliosides into
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myelin liposomes resulted in a dramatic reduction in their aggregation. However, adding
sphingomyelin to myelin lipids did not affect liposomes aggregation (Figure 3.33 B). Alto-
gether, these data demonstrate a repulsive effect of negatively charged glycoproteins and
glycolipids in myelin layers interaction.
Figure 3.33: Exogenous administration of gangliosides reduces adhesiveness of myelin-
like membrane. (A) Total brain gangliosides (80 µM) coupled to defatted BSA were loaded to fully
differentiated oligodendrocytes for 1 hr at 37 °C. After extensive washing with PBS, binding assay
was performed. Treatment of cells with gangliosides resulted in a decrease in myelin particles
binding (n = 6, ***p < 0.001; t-test). (B) Exogenous lipids were added to myelin lipids to ob-
tain 10% of total concentration and liposome aggregation assay was performed. Liposomes that
contained gangliosides revealed less aggregation in contrast to sphingomyelin (SM) and phos-
phatidylcholine (PC) -incorporated vesicles (n = 4 ***p < 0.001; one-way ANOVA)
Down-regulation of sialic acid is essential for myelination in the CNS (Fewou et al., 2007).
The polymer of sialic acid, PSA, is the prominent form of this sugar in producing repulsive
effect on membranes (Rutishauser et al., 1990). The down-regulation of PSA during oligo-
dendrocyte differentiation has been reported (Trotter et al., 1989; Bartsch et al., 1990).
This polymer is biosynthesized by polysialyltransferases which include ST8Sia II (STX)
and ST8Sia IV (PST). The main enzyme in oligodendrocyte is, however, PST (Stoykova
et al., 2001). We found a reduction in the expression of this enzyme after OLs enter
differentiation stage. Western blot analysis indicated a decrease in PST level for cells at
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Figure 3.34: Polysialyl-transferase
(ST8SiaIV) is down-regulated dur-
ing OL maturation. Oligodendrocyte
lysates from cells at day 1, 3 and 5
were analyzed for the expression lev-
els of their main polysialyl-transferase,
ST8SiaIV, using western blotting. An
obvious reduction in the level of this
protein is shown during the cell matu-
ration.
day 3 and 5 compared to day 1 (Figure 3.34). The mice expressing this enzyme in ma-
ture oligodendrocytes (PLP-PST) have been described before. These mice develop myelin
with structural abnormalities like redundant myelin and axonal degeneration (Fewou et al.,
2007). We performed electron microscopic analysis of the optic nerve from these trans-
genic mice. Conventional embedding preparation of nerve revealed more lamella splitting
for these animals compared to the controls (Figure 3.35). We also carried out the myelin-
myelin interaction assay in vitro for these mice. We observed a significant reduction in
the interaction between PST-transgenic myelin particles compared to WT myelin (Fig-
ure 3.36). These data suggest a repulsive effect of PSA on myelin adhesion in vivo and in
vitro.
3.2.10 PLP achieves its function upon sialic acid removal
Having identified an adhesive role for PLP in myelin membrane, we asked whether we
can induce myelin particle interaction with a non-myelin membrane upon expression of
this protein. We used PtK2 cell line as a model system. We transfected these cells
with PLP plasmid for 20 hr and performed the particle binding assay. However, a subtle
difference was detected for PLP-expressing cells compared to the controls. Interestingly,
when we treated cells with sialidase, a considerable increase in myelin particle interaction
was observed for cells which expressed PLP (Figure 3.37 A, B). This finding suggests that
adhesive function of PLP depends on sialic acid removal from the membrane, highlighting
the importance of glycocalyx elimination during myelin membrane compaction in the CNS.
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Figure 3.35: PSA-expressing oligodendrocytes produce less stable myelin. Optic nerves
from 5-month-old mice were prepared by conventional embedding fixation. Electron micrographs
of the samples were obtained and the average distance between myelin lamella was measured.
An increase in myelin lamella splitting (arrowheads) occurred for samples from PLP-PST mice
compared to WT (n = 15 images from 3 animals, ***p < 0.001; t-test). Scale bar, 1 µm.
Figure 3.36: PSA expression reduces the interaction between myelin particles. Myelin par-
ticles were labeled with two different PKH dyes. After incubation for 1 hour at room temperature,
the mixture of particles was applied onto coverslips and then fixed. A higher interaction (arrow-
heads) between WT particles was detected compared to the PLP-PST myelin. (n = 3, **p < 0.01;
t-test). Scale bar, 20 µm.
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Figure 3.37: PLP expression and sialic acid removal trigger myelin particle binding to non-
myelin membranes. (A) PtK2 cells were transfected with PLP-myc plasmid for 20 hr. The cells
were subsequently treated with 5 U/ml sialidase or control buffer for 1 hr at 37 °C. Addition of
myelin particles revealed more binding for sialidase-treated PLP expressing cells. PLP transfected
cells which were treated by control buffer did not show more binding compared to the controls (n
= 3, ***p < 0.001; t-test). (B) Enzymatic sialic acid removal in PtK2 cells was confirmed by WGA
staining. Scale bar, 20 µm.
Chapter 4
Discussion
4.1 The function of oligodendrocyte exosomes in the CNS
4.1.1 Regulation of oligodendrocyte development
The development of myelinating oligodendrocytes from their precursors is a complex pro-
cess which is regulated by intrinsic genetic differentiation program that is controlled par-
tially by an intracellular molecular clock determining the entry of these cells to differenti-
ation phase (Temple and Raff, 1986; Barres et al., 1994; Dugas et al., 2007). This intrinsic
program is regulated by various extrinsic factors such as Wnt, Lingo-1 and PSA-NCAM
which present within the surrounding microenvironment (Wang et al., 1998; Charles et al.,
2000; Mi et al., 2005). After OLs enter differentiation stage, they start to synthesize large
amounts of myelin components. However, the assembly of myelin membrane sheaths occurs
after the biosynthesis of the major myelin components. In fact, OLs that have produced
myelin components but have not started to enwrap axons are found for a relatively short
period during the CNS development (Trapp et al., 1997). These premyelinating cells seem
to produce different myelin components by distinct mechanisms, which might prevent pre-
mature and inappropriate assembly of the membrane. Therefore, it is feasible that the
regulation of membrane trafficking is a mechanism to induce myelin membrane assembly
at the proper time during development. Indeed, previous studies have shown that neurons
influence the trafficking of PLP (Trajkovic et al., 2006; Kippert et al., 2007). A quite large
fraction of PLP is transported to late endosomes/lysosomes (LE/Ls) in oligodendrocytes,
whereas in the presence of neurons the localization of PLP to LE/Ls is reduced (Trajkovic
et al., 2006). These late endosomal multivesicular bodies (MVBs) can either be delivered
to the endosomal pathway for lysosomal degradation, or they undergo fusion with the
plasma membrane to release their intraluminal vesicles into the extracellular space which
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are called exosomes.
4.1.2 Exosomes secreted by oligodendrocytes inhibit myelination process
Exosomes are a new type of microvesicles which are produced by different types of cells
(Simons and Raposo, 2009). The production of exosomes by oligodendrocytes has been
also reported (Kra¨mer-Albers et al., 2007). The secretion of PLP-containing exosomes
by oligodendrocytes occurs in a ceramide-dependent manner which is different from the
ESCRT-mediated exosomes formation (Trajkovic et al., 2008). Nevertheless, the physio-
logical function of exosomes secreted by oligodendrocytes still remains obscure. Here we
investigated the role of oligodendrocyte-derived exosomes during the axon-glia interaction.
Our data demonstrated that exosomes reduce OLs surface expansion and consequently in-
hibit myelination. Moreover, we found that a factor(s) from conditioned neuronal medium
reduces exosome release by OLs. Based on our findings, we propose a model where in
the absence of neuronal signals, exosomes secreted by OLs maintain these cells in pre-
myelinating stage. However, neuronal factors reduce exosome release by OLs and remove
the auto-inhibitory function of these vesicles. Therefore, the inhibitory effect of neuronal
signals on exosome release seems to be a positive mechanism to enhance myelination.
4.1.3 Exosomes inhibit terminal differentiation of OLs to become myelinating
cells
Exosomes do not affect the differentiation of oligodendrocytes from precursor cells; instead,
they appear to regulate the growth properties of these cells. Among the various factors
that have been reported to affect the life cycle of oligodendrocytes, many of them influence
the switching of proliferating OPCs into post-mitotic mature oligodendrocytes (Chong and
Chan, 2010). Many of these cues are produced by neurons and seem to reduce the differen-
tiation of oligodendrocytes rather than enhancing it. For instance, PSA-NCAM expressed
on the axonal surface and the Notch receptor Jagged1 inhibit OPCs differentiation (Wang
et al., 1998; Charles et al., 2000). Other factors that prevent OPCs differentiation are
the Wnt signalling pathway, Lingo-1 and the connective tissue growth factor (CTGF) (Mi
et al., 2005; Stritt et al., 2009; Ye et al., 2009)). In chronic MS lesions the activation
of these pathways might be responsible for the differentiation obstruct that subsequently
4.1 The function of oligodendrocyte exosomes in the CNS 77
results in inefficient remyelination (Franklin and Ffrench-Constant, 2008). In addition,
premyelinating oligodendrocytes have been detected in chronic MS lesions that extend
multiple myelin components-positive processes (Chang et al., 2002). These cells have en-
tered the differentiation phase, but failed to remyelinate lesion, probably because they are
not receiving the proper signals from the chronically demyelinated axons. Pre-myelinating
cells are not normally present in the healthy adult brain, but rather they appear for a
relatively short period during CNS development (Trapp et al., 1997). It is feasible that
neuronal signals reduce the generation of MVBs and thereby the biogenesis of new exo-
somes at later stages of oligodendrocyte development. It is also possible that microvesicles
are generated directly from the blebbing of plasma membrane into the extracellular space.
Interestingly, the premyelinating cells which have been observed in chronic MS lesions
include large perikarya positive for PLP (Chang et al., 2002). It will be interesting to find
out whether this PLP fraction accumulates in late endosomes/lysosomes and is secreted
via exosomes in these premyelinating oligodendrocytes.
4.1.4 Exosomes influence OLs through a common signalling pathway triggering
cell retraction
The signals responsible for the regulation of exosome release are unknown, but they may
lead to alteration intracellular Ca2+ levels that are known to increase exosomal secretion
(Kra¨mer-Albers et al., 2007). In turn, these vesicles might induce a variety of signalling
cascades in the target cells. We found that the effect of exosomes on OLs is mediated by
RhoA signalling. This pathway has been described to regulate OLs branching (Kippert
et al., 2009). Inhibition of RhoA function is essential for OLs to extend their processes
during myelination. Exosomes seem to employ this common signalling pathway to induce
OLs retraction. Src family kinase in particularly Fyn protein have been described to play
a role in myelination of the CNS (Sperber et al., 2001). We also found the involvement of
Fyn protein during OLs treatment by exosomes. This protein is known to control RhoA
signalling pathway in oligodendrocytes. The activity of this protein is regulated by two
different phosphorylation sites. Whereas phosphorylation of tyrosine 420 increases Fyn
activity, the addition of a phosphate group to tyrosine 531 inhibits the activity. Therefore,
numerous factors modulate Fyn activity by changing its phosphorylation pattern. Exo-
somes inhibit Fyn activity by reducing the phosphorylation of tyrosine 420 whereas they
do not affect the phosphorylation level of tyrosine 531. The activity of Fyn to regulate
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myelination by OLs is connected to another kinase, focal adhesion kinase (FAK). This
protein is described to mediate integrin signalling in oligodendrocytes which consequently
results in myelination in response to ECM factors (Caˆmara et al., 2009; Forrest et al.,
2009). Exosome-induced alteration of FAK phosphorylation revealed the involvement of
this protein in the process. We observed that exosomes reduce autophosphorylation of
FAK (Y397). Therefore, we conclude that by inactivation of FAK and Fyn proteins,
exosomes activate the RhoA cascade which subsequently induces oligodendroglial cell re-
traction.
4.1.5 Exosomes and myelin debris have the same effect on OLs
It is interesting to compare the effects of exosomes to myelin debris released upon demyeli-
nation. Myelin debris has a great inhibitory effect on oligodendrocyte differentiation unless
they are removed from the extracellular space by phagocytic cells (Miller, 1999; Kotter
et al., 2001, 2006). Injection of exogenous myelin in regions of experimentally induced
focal demyelination leads to inhibition of remyelination by preventing OPC differentiation
(Kotter et al., 2006). Interestingly, this inhibitory effect of myelin on OL differentiation
is mediated by Fyn-RhoA-ROCK signalling (Baer et al., 2009). These observations show
that so far unknown molecules presented by both myelin debris and exosomes regulate re-
markably similar processes by a common signalling cascade. An alternative explanation is
that the myelin membrane proteins are only cargo and another unidentified protein medi-
ates this effect. Candidate molecules are such as Lingo-1 that activates the RhoA-ROCK
pathway and reduces Fyn expression and activation (Mi et al., 2005). Also, Netrin-1 has
been described to modulate oligodendrocyte process branching and membrane extension
via Fyn and RhoA pathway (Rajasekharan et al., 2009). It is not clear why there are
so many inhibitory molecules to control myelin membrane formation and assembly in the
CNS, whereas in the PNS many inductive factors have been reported to regulate myeli-
nation process by Schwann cells. One possible reason for this could be the complex task
of coordinating the biosynthesis of up to 40 myelin fragments on different axons by one
oligodendrocyte. Therefore, the removal of inhibitory factors from the oligodendrocyte
microenvironment may trigger the myelination of all processes at the same time.
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4.2 Myelin adhesion and compaction in central nervous system
4.2.1 Myelin compaction and a new model system for its assessment
One defining characteristic of myelin is its compact structure, which is achieved by the
close adhesion of the different membrane layers. The interaction between layers in cy-
toplasmic sides is known to be mediated by MBP function to generate the major dense
line. However, the molecular mechanisms that generate the intraperiod line (IPL) which
is localized between the outer leaflets of the myelin membrane are poorly understood.
The major obstacle to investigate this structure is technical limitation. The information
so far on myelin compaction are mainly based on electron microscopy studies of mutant
animals. However, these approaches have not clearly elucidated the mechanism of myelin
compaction in the extracellular space.
Oligodendrocytes are known to produce myelin membrane in vitro. In culture, OPCs dif-
ferentiate into mature OLs in the absence of neuronal signals and produce large amounts
of membrane surronding their perikarya. The morphological and biochemical characteri-
zation of this membrane reveals a high similarity to myelin structure in vivo. The protein
markers for the compact and non-compact areas are nicely separated in this myelin-like
membrane (Aggarwal et al., 2011b). Therefore, this membrane can be a useful model
for structural studies regarding CNS myelin in the cell culture system. Taking advantage
of this model we established a biding assay between purified myelin particles and oligo-
dendrocytes in culture to mimic the interaction between two myelin membranes in vitro.
Interestingly, the interaction between myelin and oligodendrocytes seems to be specific,
since these particles have low affinity towards other glial cells. Therefore, we introduce
this system as a model to analyse the possible molecular mechanisms involved in myelin
compaction.
4.2.2 The role of PLP in myelin adhesion and compaction
It has been proposed that the interaction between hydrophilic extracellular domains of
PLP may be responsible for tight opposition of membrane sheaths enwrapping axons
that leads to the compaction of myelin layers (Weimbs and Stoffel, 1992). To address
this question two independent groups have designed mice lacking the plp gene. Boison
and colleague generated a PLP -knockout mouse, and showed that axons are loosely en-
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wrapped by myelin, displaying wide extracellular spaces between lamella. Despite the
abnormality in myelin compaction, these mice were fertile and had a normal life-span
without noticeable behavioural symptoms (Boison et al., 1995). In contrast, Klugmann
and colleague generated another PLP/DM20-knockout mice (KPLP) which revealed nor-
mal myelin biosynthesis and assembly by oligodendrocytes. These results challenged the
previous report that proposed an adhesive role for PLP during myelin assembly, suggesting
an engagement of its homophilic interaction to form struts to stabilize the IPL (Klugmann
et al., 1997). These animals did not show a clear loss of oligodendrocytes and displayed
normal myelin synthesis and assembly suggesting that PLP is not essential for myelination
in the CNS (Klugmann et al., 1997; Rosenbluth et al., 2006; Mo¨bius et al., 2008). However,
normal myelination in PLP -null mice was followed by progression of a widespread axonal
swelling and degeneration. This axonal swelling has been shown to be a consequence of the
absence of PLP and not of abnormal myelin morphology, which also appears in shiverer
mice without inducing the same pathological symptoms (Griffiths et al., 1998b).
Using myelin and oligodendrocytes from KPLP mice we investigated the function of PLP
during the interaction between myelin particles and primary oligodendrocytes. We found
a decrease in myelin particles binding to OLs in the absence of PLP. Further, the adhesion
between myelin particles was increased in the presence of PLP. We also found more aggre-
gation between liposomes prepared from WT myelin in comparison to those from KPLP
myelin. This is consistent with the observation that PLP induces rolling, but not fusion of
lipid bilayer, indicating the capability of this protein in creating myelin-like structures in
vitro (Palaniyar et al., 1998). Furthermore, PLP has been reported to induce PC/choles-
terol vesicle aggregation, which is abolished upon disulfide bonds cleavage and methylation
of carboxyl group in the protein (Bizzozero and Howard, 2002). This observation has in-
dicated a potent role of PLP in neutral vesicle clustering that is dependent on the protein
conformation. Our findings together with previous data suggest an adhesive role for PLP
protein in vitro, which proposes that even if this protein is not necessary for myelin bio-
genesis, it is required for stability and maintenance of myelin layers in compacted area.
4.2.3 The involvement of PLP in supporting the physical integrity of CNS myelin
If PLP has adhesive property, it most likely increases the physical stability of myelin.
To examine this, the size distribution of myelin particles was analyzed which displayed a
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tendency toward larger sizes for WT myelin compared to KPLP. This shows the fragility
of myelin in the absence of this protein. The yield of myelin preparation from PLP null
mice is also less than WT. Additionally, the mature myelin from PLP knockout mice is
more fragmented throughout the preparation which indicates a lower physical stability of
this membrane (Jurevics et al., 2003). Single-particle force spectroscopy revealed stronger
interaction between myelin membranes in the presence of PLP. Also, a fluctuation assay
indicated an increase in myelin flexibility in the absence of PLP. Together these obser-
vations indicate the lower physical stability of KPLP myelin, supporting the structural
function of this protein in stabilizing the integriy of myelin membrane. We also analyzed
the average distance between lamella in KPLP myelin from optic nerve using electron
microscopy. Embedding fixation of nerve preparation revealed more splitting in myelin
lamella for KPLP compared to the control. These data are consistent with the observation
that have shown more interalamellar space and looser myelin in PLP -null mice (Rosen-
bluth et al., 2006). In addition, it has been shown that myelin sheaths of compact area
appeared split into two leaflets and IPL were unfused with more extracellular space than
wild-type mice (Rosenbluth et al., 2006). Nevertheless, these myelin split lamella have
not been observed upon cryofixation and freeze substitution of samples with careful tissue
processing. Based on this observation, it has been speculated that the split lamella may
correspond to fixation artifact during sample preparation and not occurs in PLP -null mice
in vivo (Mo¨bius et al., 2008). However, even if this splitting occurs during sample prepa-
ration it shows a greater fragility of myelin in the absence of PLP, which demonstrates the
structural role of PLP in the stabilization of myelin membrane integrity. It is, therefore,
possible that myelin is indeed of normal ultrastructure in a living animal lacking PLP as
suggested by Klugmann and colleague (Klugmann et al., 1997).
The importance of PLP in myelin integrity has also become clear from mice deficient
for PLP together with other myelin components. OSP/claudin-11 and PLP are struc-
turally related and are tetraspan proteins. Generating mice deficient for both PLP and
OSP/claudin-11, have produced severe neurological deficits with disrupted myelin com-
paction of smaller axonal calibres compared to the single knockouts (Chow et al., 2005).
This suggests that these proteins have compensatory function for each other as the ab-
sence of both of them leads to severe deficits. Also, in the mice deficient for PLP and
galactocerbrosides a large number of axons in the ventral spinal white matter and the optic
nerve were unmyelinated (Coetzee et al., 1999). These observations indicate the involve-
82 4 | Discussion
ment of PLP and galactolipids in maintenance of myelin integrity. They also suggest that a
series of complex interaction may be required for formation of IPL and myelin compaction.
4.2.4 Oligodendrocyte glycocalyx is reduced during their maturation
The adhesion process between two membranes is controlled by expression of adhesion re-
ceptors, intrinsic activity of these molecules, their organization in the cell membrane, and
non-specific process such as glycocalyx removal (Vitte et al., 2005). In general, cells are
surrounded by a carbohydrate-rich layer, which collectively called glycocalyx (Foa et al.,
1996). Despite specific interactions between glycocalyx elements such as interaction of
integrins and syndecans to ECM components (Weinbaum et al., 2007), cells use the gly-
cocalyx to modulate their adhesiveness. Presence of glycocalyx impedes adhesion and,
therefore, its removal is required for establishment of efficient interaction between two
membranes. Here, we showed a downregulation of glycoconjugate molecules from the sur-
face of oligodendrocytes during maturation which seems to be a mechanism to increase
myelin membrane adhesion. Using different lectins, we showed that numerous types of
sugars are reduced from fully differentiated OLs. Accordingly, lectin staining for adult
brain clearly revealed a negative correlation between lectin binding and myelination. The
major molecule responsible for repulsive inhibition of cell adhesion is sialic acid. Due to
its negative charge, sialic acid induces a non-specific repulsive force between membranes.
Mature oligodendrocytes and myelinated areas in the adult brain had low amounts of this
molecule. Additionally, enzymatic removal of sialic acid increased myelin-like membrane
adhesiveness which supports its role in myelin adhesion and compaction. Interestingly, a
reduction in myelinated axons in sialin (lysosomal sialic acid transporter) deficient mice
has been described (Prolo et al., 2009). This might support the necessity of sialic acid
removal in the myelination process of the CNS .
4.2.5 The mechanisms involved in glycocalyx removal from OLs surface
The reduction of glycocalyx from the myelin surface could be regulated by three possible
mechanisms; down-regulation of the glycocalyx synthesis machinery, enzymatic removal
and glycoproteins exclusion from myelin compact area. Transcriptome analysis of oligo-
dendrocytes has revealed a striking reduction in the expression levels of many enzymes
involved in glyco-conjugate synthesis during differentiation (Dugas et al., 2006). We also
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found a reduction in sialic acid synthesis using metabolic incorporation labeling during
maturation of oligodendrocytes. This down-regulation of the synthesis machinery might
be an intrinsic program for cells to reduce their carbohydrate production after entering
the differentiation phase. Indeed, proliferating oligodendrocyte precursors contain many
glycocalyx components such as NG2 proteoglycan that are eliminated in mature cells
(Nishiyama et al., 2009). Another feasible mechanism for the glycocalyx removal from
myelin is enzymatic degradation. The main evidence especially regarding sialic acid re-
moval is provided by finding the intrinsic sialidase activity of myelin. Myelin prepared
from rat brain shows intrinsic sialidase activity, that is elevated during the period of ac-
tive myelination (Saito and Yu, 1986, 1993). In addition, a correlation between sialidase
activity and MBP distribution has been described in adult mice brains, which indicates
the importance of myelin associated sialidase in myelin maintenance and stability (Minami
et al., 2011). This is consistent with our observation that showed low amounts of sialic
acids in myelinated areas. One substrate of myelin sialidase can be gangliosides. These
lipids exist in myelin as a minor species and are requisite for long-term integrity of axon-
myelin interaction (Cochran et al., 1982). Oligodendrocytes are able to synthesize many
brain types of gangliosides (Lopez and Schnaar, 2009). However, in mature myelin, many
of these lipids are absent and GM1 is the main type (Cochran et al., 1982). Whether se-
lective incorporation of these lipids into myelin or enzymatic removal by sialidase, results
in a low density of gangliosides in mature myelin, still remain to be proven (Yu et al.,
1989). The fact that GM1 as the main ganglioside in mature myelin is resistant to degra-
dation by sialidase (Li et al., 2001), might supports the role of this enzyme in removing
other gangliosides from myelin. MBP function in myelin can also reduce the glycoprotein
content of myelin compact area. This protein acts as a barrier and prevents the entry of
proteins with large cytosolic domain to compact region (Aggarwal et al., 2011b). Most of
these proteins are, indeed, glycoproteins which are restricted to the non-compact region
in mature myelin. Therefore, by reducing glycoprotein content, MBP might indirectly
facilitates myelin adhesion in extracellular leaflets. This is interesting since this protein
orchestrates the interaction between membranes in cytoplasmic sides. Our observation
that myelin particles bound more to WT cells than shiverer, which do not have MBP,
also supports this idea. Interestingly, introducing of MAG to compacted region also re-
duced myelin binding, pointing to the necessity of exclusion of glycoproteins by the size
barrier function of MBP during myelin development.
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4.2.6 Down-regulation of sialic acid content is necessary for myelin compaction
We found that enzymatic removal of sialic acid in both myelin-like and non-myelin mem-
branes increases their adhesiveness towards myelin particles. Furthermore, exogenous
incorporation of gangliosides, as a major source of sialic acid, attenuated myelin adhesion.
Interestingly, the reduction of sialic acid polymer, PSA, from myelinating cells is necessary
for efficient myelination in the CNS. Transgenic mice expressing PSA (PLP-PST) in ma-
ture oligodendrocytes develop myelin structural abnormalities such as redundant myelin,
axonal and vacular degeneration (Fewou et al., 2007). By analyzing the optic nerve from
PLP-PST mice we revealed more splitting of myelin lamella which indicates less stability
of this myelin. Moreover, myelin particles from PLP-PST mice exhibited less adhesion in
comparison to WT. Therefore, we suggest that the reduction of PSA from mature myelin
might be necessary for the tight adhesion of this membrane from the extracellular sides
to organize a compacted structure. Post-translationally addition of PSA to proteins plays
important roles in the CNS. PSA-NCAM, for example, is involved in axonal pathfinding
and branching, cell migration and synaptic plasticity in the CNS (Charles et al., 2002).
To be myelinated, axons eliminate PSA-NCAM from their surface (Jakovcevski et al.,
2007), suggesting the repulsive effect of PSA on myelinating glia to approach the axons.
Additionally, re-expression of PSA on the surface of demyelinated axons possibly prevents
remyelination (Charles et al., 2000, 2002). This may suggests a possible molecular mech-
anism responsible for a partially remyelination failure in multiple sclerosis.
Chapter 5
Summary and conclusion
Previous studies have reported that oligodendrocytes produce relatively large amounts
of exosomes, but the physiological role of these vesicles has remained unclear. Here, we
investigated the function of oligodendrocyte-derived exosomes using a cell culture sys-
tem. In summary, we showed that oligodendrocyte secrete exosome-like vesicles that seem
to have an auto-inhibitory effect by reducing oligodendrocyte surface growth. Interest-
ingly, we found that factors from the neuronal conditioned medium reduce the secretion
of exosome-like vesicles from oligodendrocytes. Based on these observations, we propose
a model in which neurons regulate terminal differentiation of oligodendrocytes by control-
ling the release of auto-inhibitory exosomes from these myelinating cells (Figure 5.1).
We also found that the effect of exosomes on OLs is mediated by inactivation of FAK-Fyn
signalling which leads to activation of RhoA-ROCK pathway. This cascade has been de-
scribed to regulate OLs process branching and its inhibition is essential for OLs to extend
their branches. Therefore, exosomes seem to employ this common signalling pathway to
induce OLs retraction. In conclusion, our results provide new evidence for small and dif-
fusible oligodendroglial-derived vesicular carriers within the extracellular space that have
inhibitory properties on cellular growth. We propose that secretion of these exosomes
coordinate myelin membrane biogenesis.
In the second part, we studied the mechanisms responsible for adhesion and compaction
of CNS myelin. We established a binding assay to assess the interaction betwen purified
myelin particles and primary oligodendrocytes in culture to mimic the interaction between
two myelin membranes. Using this model system we investigated the possible role of
PLP as a putative adhesion molecule in myelin membrane adhesion. Our data indicated
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Figure 5.1: A model for the function of oligodendrocyte-derived exosomes. Oligodendro-
cytes release exosomes which keep cells in premyelinating stage and inhibit myelination. Neu-
ronal signals reduce the secretion of exosomes by OLs and, therefore, remove the inhibitory effect
of these vesicles on myelination.
an adhesive properties of this protein in myelin membranes interaction. We confirmed
this observation by performing liposome aggregation assay prepared from myelin-derived
lipids. We also found the role of PLP in increasing myelin stability using single particle
force spectroscopy. Electron microscopy analysis of optic nerve from PLP knockout mice
also revealed the involvement of PLP in maintenance and stability of myelin integrity.
Taken together we provide evidence for the contribution of PLP in myelin adhesion which
increases the physical stability of this membrane.
To establish an efficient membrane adhesion the repulsive molecules should be removed
from the surface. Therefore, we explored the involvement of glycocalyx removal in myelin
adhesion during maturation of this membrane. We showed a clear reduction in carbo-
hydrates from OLs surface during their maturation by lectin staining. Staining of brain
section also revealed a reduction of glycocalyx content from myelinated areas. Further-
more, we found a role of sialic acids as a repulsive molecule in myelin adhesion. Enzymatic
removal of sialic acid and its exogenous incorporation support the repulsive effect of this
molecule on myelin adhesiveness. In addition, electron microscopic analysis of optic nerve
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Figure 5.2: A model for myelin adhesion and compaction in CNS. Our data suggests that
the removal of the glycocalyx components, mainly sialic acid, along with adhesive function of PLP
orchestrate CNS myelin membrane adhesion and compaction in the extracellular sides.
from transgenic mice expressing polysialic acid (PSA) in mature oligodendrocytes as well
as myelin particle binding assay from these mice revealed a reduction in myelin adhesion.
Our data, therefore, suggest that the removal of glycocalyx is necessary for myelin mem-
brane adhesion. In conclusion, our data suggest that glycocalyx is reduced from myelin
membrane during its maturation which leads to exposure of adhesion molecules such as
PLP to orchestrate the interaction between myelin membrane layers which subsequently
establish myelin compaction (Figure 5.2).
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